# EDGAR Filing Document

**Accession Number:** 0000912093
**File Stem:** 0001628280-26-028926
**Filing Date:** 2026-4
**Character Count:** 279037
**Document Hash:** 0c522bde70992d9843b29dbe6025ae48
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-028926.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001628280-26-028926

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 103

**CONFORMED PERIOD OF REPORT**: 20260328

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VIAVI SOLUTIONS INC.
- **CENTRAL INDEX KEY:** 0000912093
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 942579683
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0627

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-22874
- **FILM NUMBER:** 26925929

**BUSINESS ADDRESS:**
- **STREET 1:** 1445 SOUTH SPECTRUM BLVD.
- **STREET 2:** SUITE 102
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85286
- **BUSINESS PHONE:** 4084043600

**MAIL ADDRESS:**
- **STREET 1:** 1445 SOUTH SPECTRUM BLVD.
- **STREET 2:** SUITE 102
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JDS UNIPHASE CORP /CA/
- **DATE OF NAME CHANGE:** 19990713

?xml version='1.0' encoding='ASCII'? viav-20260328

    

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 28, 2026**

 **OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

---

| | |
|:---|:---|
| **For the transition period from** | **to** |

---

**Commission File Number 000-22874** 

**Viavi Solutions Inc.**

(Exact name of Registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **94-2579683** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification Number) |

---

 **1445 South Spectrum Blvd, Suite 102, Chandler, Arizona 85286** 

(Address of principal executive offices including Zip code)

**(408) 404-3600** 

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of the exchange on which registered** |
| Common Stock, par value of $0.001 per share | VIAV | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ | Non-accelerated filer <br>(Do not check if a smaller reporting company) | ☐ | Smaller reporting company | ☐ | Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |

---

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 25, 2026, the Registrant had 233,907,870 shares of common stock outstanding.

    

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

---

| | | |
|:---|:---|:---|
| **TABLE OF CONTENTS** | **TABLE OF CONTENTS** | **<u>Page</u>** |
| <u>[PART I - FINANCIAL INFORMATION](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[PART I - FINANCIAL INFORMATION](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[2](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> |
| <u>[Item 1.](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[Financial Statements (Unaudited)](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[2](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> |
|  | <u>[Consolidated Statements of Operations for the Three and Nine Months Ended March 28, 2026 and March 29, 2025](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[2](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> |
|  | <u>[Consolidated Statements of Comprehensive (Loss) Income for the](#i9d5e57b28a2a4895b07b82f12543ee34_13)[Three and Nine Months Ended March 28, 2026 and March 29, 2025](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[3](#i9d5e57b28a2a4895b07b82f12543ee34_13)</u> |
|  | <u>[Consolidated Balance Sheets as of](#i9d5e57b28a2a4895b07b82f12543ee34_16)[March](#i9d5e57b28a2a4895b07b82f12543ee34_16)[2](#i9d5e57b28a2a4895b07b82f12543ee34_16)[8](#i9d5e57b28a2a4895b07b82f12543ee34_16)[, 202](#i9d5e57b28a2a4895b07b82f12543ee34_16)[6](#i9d5e57b28a2a4895b07b82f12543ee34_16)[and June 28, 2025](#i9d5e57b28a2a4895b07b82f12543ee34_16)</u> | <u>[4](#i9d5e57b28a2a4895b07b82f12543ee34_16)</u> |
|  | <u>[Consolidated Statements of Cash Flows for the](#i9d5e57b28a2a4895b07b82f12543ee34_22) Nine</u><u>[Months Ended March 28, 2026 and March 29, 2025](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[5](#i9d5e57b28a2a4895b07b82f12543ee34_22)</u> |
|  | <u>[Consolidated Statements of Stockholders' Equity for the](#i9d5e57b28a2a4895b07b82f12543ee34_28)[Three and Nine Months Ended March 28, 2026 and March 29, 2025](#i9d5e57b28a2a4895b07b82f12543ee34_10)</u> | <u>[6](#i9d5e57b28a2a4895b07b82f12543ee34_28)</u> |
|  | <u>[Notes to Consolidated Financial Statements](#i9d5e57b28a2a4895b07b82f12543ee34_37)</u> | <u>[8](#i9d5e57b28a2a4895b07b82f12543ee34_37)</u> |
| <u>[Item 2.](#i9d5e57b28a2a4895b07b82f12543ee34_142)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i9d5e57b28a2a4895b07b82f12543ee34_142)</u> | <u>[37](#i9d5e57b28a2a4895b07b82f12543ee34_142)</u> |
| <u>[Item 3](#i9d5e57b28a2a4895b07b82f12543ee34_262)</u>. | <u>[Quantitative and Qualitative Disclosure About Market Risks](#i9d5e57b28a2a4895b07b82f12543ee34_262)</u> | <u>[53](#i9d5e57b28a2a4895b07b82f12543ee34_262)</u> |
| <u>[Item 4.](#i9d5e57b28a2a4895b07b82f12543ee34_265)</u> | <u>[Controls and Procedures](#i9d5e57b28a2a4895b07b82f12543ee34_265)</u> | <u>[54](#i9d5e57b28a2a4895b07b82f12543ee34_265)</u> |
| <u>[PART II - OTHER INFORMATION](#i9d5e57b28a2a4895b07b82f12543ee34_268)</u> | <u>[PART II - OTHER INFORMATION](#i9d5e57b28a2a4895b07b82f12543ee34_268)</u> | <u>[55](#i9d5e57b28a2a4895b07b82f12543ee34_268)</u> |
| <u>[Item 1.](#i9d5e57b28a2a4895b07b82f12543ee34_271)</u> | <u>[Legal Proceedings](#i9d5e57b28a2a4895b07b82f12543ee34_271)</u> | <u>[55](#i9d5e57b28a2a4895b07b82f12543ee34_271)</u> |
| <u>[Item 1A.](#i9d5e57b28a2a4895b07b82f12543ee34_274)</u> | <u>[Risk Factors](#i9d5e57b28a2a4895b07b82f12543ee34_274)</u> | <u>[56](#i9d5e57b28a2a4895b07b82f12543ee34_274)</u> |
| <u>[Item 2.](#i9d5e57b28a2a4895b07b82f12543ee34_277)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i9d5e57b28a2a4895b07b82f12543ee34_277)</u> | <u>[71](#i9d5e57b28a2a4895b07b82f12543ee34_277)</u> |
| <u>[Item 3.](#i9d5e57b28a2a4895b07b82f12543ee34_283)</u> | <u>[Defaults Upon Senior Securities](#i9d5e57b28a2a4895b07b82f12543ee34_283)</u> | <u>[71](#i9d5e57b28a2a4895b07b82f12543ee34_283)</u> |
| <u>[Item 4.](#i9d5e57b28a2a4895b07b82f12543ee34_286)</u> | <u>[Mine Safety Disclosures](#i9d5e57b28a2a4895b07b82f12543ee34_286)</u> | <u>[71](#i9d5e57b28a2a4895b07b82f12543ee34_286)</u> |
| <u>[Item 5.](#i9d5e57b28a2a4895b07b82f12543ee34_289)</u> | <u>[Other Information](#i9d5e57b28a2a4895b07b82f12543ee34_289)</u> | <u>[71](#i9d5e57b28a2a4895b07b82f12543ee34_289)</u> |
| <u>[Item 6.](#i9d5e57b28a2a4895b07b82f12543ee34_295)</u> | <u>[Exhibits](#i9d5e57b28a2a4895b07b82f12543ee34_295)</u> | <u>[71](#i9d5e57b28a2a4895b07b82f12543ee34_295)</u> |
| <u>[SIGNATURES](#i9d5e57b28a2a4895b07b82f12543ee34_298)</u> | <u>[SIGNATURES](#i9d5e57b28a2a4895b07b82f12543ee34_298)</u> | <u>[72](#i9d5e57b28a2a4895b07b82f12543ee34_298)</u> |

---

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**PART I—FINANCIAL INFORMATION**

 **Item 1. Financial Statements** 

**VIAVI SOLUTIONS INC.** 

**CONSOLIDATED STATEMENTS OF OPERATIONS**

**(in millions, except per share data)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| **Revenues:** | | | | |
| &nbsp;&nbsp;&nbsp;Product revenue | $357.0 | $241.5 | $931.7 | $664.7 |
| &nbsp;&nbsp;&nbsp;Service revenue | 49.8 | 43.3 | 143.5 | 129.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenue | 406.8 | 284.8 | 1075.2 | 793.8 |
| **Cost of revenues:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Product cost of revenue | 141.6 | 96.7 | 377.7 | 265.9 |
| &nbsp;&nbsp;&nbsp;Service cost of revenue | 18.1 | 21.3 | 51.4 | 57.6 |
| &nbsp;&nbsp;&nbsp;Amortization of acquired technologies | 13.0 | 6.1 | 32.4 | 12.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of revenues | 172.7 | 124.1 | 461.5 | 336.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 234.1 | 160.7 | 613.7 | 457.6 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 71.0 | 50.0 | 192.9 | 151.5 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative | 113.6 | 101.3 | 344.9 | 259.7 |
| &nbsp;&nbsp;&nbsp;Amortization of other intangibles | 7.4 | 1.2 | 15.2 | 3.3 |
| &nbsp;&nbsp;&nbsp;Restructuring and related charges (benefits) | 17.3 | (0.3) | 16.9 | 0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 209.3 | 152.2 | 569.9 | 415.4 |
| &nbsp;&nbsp;&nbsp;Income from operations | 24.8 | 8.5 | 43.8 | 42.2 |
| &nbsp;&nbsp;&nbsp;Loss on debt extinguishment (Note 11) | (3.7) |  | (46.2) |  |
| &nbsp;&nbsp;&nbsp;Interest and other income, net | 7.0 | 2.2 | 12.2 | 9.3 |
| &nbsp;&nbsp;&nbsp;Interest expense | (14.3) | (7.5) | (37.0) | (22.5) |
| &nbsp;&nbsp;&nbsp;&nbsp; Income (loss) before income taxes and equity investment earnings | 13.8 | 3.2 | (27.2) | 29.0 |
| Provision for (benefit from) income taxes | 7.4 | (16.3) | 36.1 | 2.2 |
| Equity investment earnings |  |  | 0.2 |  |
| Net income (loss) | $6.4 | $19.5 | $(63.1) | $26.8 |
| **Net income (loss) per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.03 | $0.09 | $(0.28) | $0.12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.03 | $0.09 | $(0.28) | $0.12 |
| **Shares used in per share calculations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 232.0 | 222.6 | 226.2 | 222.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 249.5 | 226.9 | 226.2 | 225.2 |

---

*The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.*

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**VIAVI SOLUTIONS INC.**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME**

**(in millions)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Net income (loss) | $6.4 | $19.5 | $(63.1) | $26.8 |
| Other comprehensive (loss) income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net change in cumulative translation adjustment, net of tax | (7.5) | 13.9 | (6.3) | 2.9 |
| &nbsp;&nbsp;&nbsp;Amortization of net actuarial losses and other pension adjustments |  |  | 0.1 | 0.2 |
| &nbsp;&nbsp;&nbsp;Net change in accumulated other comprehensive (loss) income | (7.5) | 13.9 | (6.2) | 3.1 |
| Comprehensive (loss) income | $(1.1) | $33.4 | $(69.3) | $29.9 |

---

*The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.*

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**VIAVI SOLUTIONS INC.**

**CONSOLIDATED BALANCE SHEETS**

**(in millions, except share and par value data)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $499.0 | $423.6 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 1.8 | 1.7 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 7.2 | 3.7 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 320.3 | 261.0 |
| &nbsp;&nbsp;&nbsp;Inventories, net | 147.9 | 117.9 |
| &nbsp;&nbsp;&nbsp;Prepayments and other current assets | 77.5 | 77.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1053.7 | 885.2 |
| Property, plant and equipment, net | 222.5 | 231.9 |
| Goodwill, net | 701.8 | 595.7 |
| Intangibles, net | 398.0 | 131.6 |
| Deferred income taxes | 79.7 | 87.2 |
| Other non-current assets | 72.1 | 62.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2527.8 | $1993.8 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $81.7 | $68.8 |
| &nbsp;&nbsp;&nbsp;Accrued payroll and related expenses | 72.8 | 63.6 |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 85.2 | 74.1 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 27.8 | 28.7 |
| &nbsp;&nbsp;&nbsp;Short-term debt | 244.5 | 246.2 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 140.5 | 108.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 652.5 | 589.7 |
| Long-term debt | 836.3 | 396.3 |
| Other non-current liabilities | 192.5 | 227.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1681.3 | 1213.6 |
| Commitments and contingencies (Note 18) |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;Preferred stock, $0.001 par value; 1 million shares authorized, no shares issued or outstanding at March 28, 2026 and June 28, 2025 |  |  |
| &nbsp;&nbsp;Common stock, $0.001 par value; 1 billion shares authorized; 234 million shares at March 28, 2026 and 223 million shares at June 28, 2025, issued and outstanding  | 0.2 | 0.2 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 70683.5 | 70517.9 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (69721.2) | (69628.1) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (116.0) | (109.8) |
| Total stockholders' equity | 846.5 | 780.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $2527.8 | $1993.8 |

---

*The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.*

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**VIAVI SOLUTIONS INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in millions)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** |
| **OPERATING ACTIVITIES:** | | |
| Net (loss) income | $(63.1) | $26.8 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation expense | 30.1 | 28.8 |
| &nbsp;&nbsp;&nbsp;Amortization of acquired technologies and other intangibles | 47.6 | 16.0 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 41.2 | 40.5 |
| &nbsp;&nbsp;&nbsp;Loss on debt extinguishment | 46.2 |  |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 4.9 | 5.5 |
| &nbsp;&nbsp;&nbsp;Net change in fair value of contingent liabilities | 24.3 | (4.9) |
| &nbsp;&nbsp;&nbsp;Deferred taxes, net | 9.5 | (29.9) |
| &nbsp;&nbsp;&nbsp;Amortization of inventory step-up | 6.1 | 1.7 |
| &nbsp;&nbsp;&nbsp;Restructuring | 16.9 | 0.9 |
| &nbsp;&nbsp;&nbsp;Other | 6.9 | (4.6) |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net of acquisitions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (62.5) | (31.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (37.3) | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current and non-current assets | (5.7) | (1.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 13.4 | 15.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 3.4 | 5.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue, current and non-current | (13.2) | (0.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued payroll and related expenses | 9.1 | 6.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current and non-current liabilities | (30.6) | (8.3) |
| Net cash provided by operating activities | $47.2 | $66.0 |
| **INVESTING ACTIVITIES:** |  |  |
| Purchases of short-term investments | $(64.6) | $(147.7) |
| Maturities of short-term investments | 64.7 | 145.5 |
| Capital expenditures | (20.0) | (22.3) |
| Proceeds from the sale of assets | 2.6 | 4.7 |
| Acquisitions, net of acquired cash and holdbacks | (399.3) | (117.9) |
| Purchase price adjustment related to business acquisition | (0.7) |  |
| Other investing activities |  | (3.0) |
| Net cash used in investing activities | $(417.3) | $(140.7) |
| **FINANCING ACTIVITIES:** |  |  |
| Proceeds from issuance of debt | $749.1 | $— |
| Repayment of debt | (199.0) |  |
| Payment of debt issuance costs | (23.4) |  |
| Repurchase and retirement of common stock | (30.0) | (16.4) |
| Withholding tax payment on vesting of restricted stock and performance- based awards | (23.0) | (13.1) |
| Cash paid to third parties in convertible note extinguishment | (1.0) |  |
| Payment of financing obligations | (0.2) | (0.2) |
| Proceeds from employee stock purchase plan | 6.5 | 6.0 |
| Payment of acquisition related contingent consideration | (29.8) |  |
| Other financing activities |  | 0.2 |
| Net cash provided by (used in) financing activities | $449.2 | $(23.5) |
| Effect of exchange rates on cash, cash equivalents and restricted cash | $0.1 | $(0.9) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 79.2 | (99.1) |
| Cash, cash equivalents and restricted cash at the beginning of the period<sup>(1)</sup> | 432.1 | 481.8 |
| Cash, cash equivalents and restricted cash at the end of the period<sup>(2)</sup> | $511.3 | $382.7 |

---

(1)These amounts include both current and non-current balances of restricted cash totaling $8.5 million and $10.5 million as of June 28, 2025 and June 29, 2024, respectively.

(2)These amounts include both current and non-current balances of restricted cash totaling $12.3 million and $8.5 million as of March 28, 2026 and March 29, 2025, respectively.

*The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.*

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

 **VIAVI SOLUTIONS INC.**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(in millions)**

**(unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** |
| | **Common Stock** | **Common Stock** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| **Balance at December 27, 2025** | 231.4 | $0.2 | $70670.2 | $(69727.6) | $(108.5) | $834.3 |
| Net income |  |  |  | 6.4 |  | 6.4 |
| Other comprehensive loss |  |  |  |  | (7.5) | (7.5) |
| Shares issued under employee stock plans, net of tax | 0.7 |  | (0.7) |  |  | (0.7) |
| Stock-based compensation |  |  | 14.0 |  |  | 14.0 |
| Convertible note extinguishment (Note 11) | 1.8 |  |  |  |  |  |
| **Balance at March 28, 2026** | 233.9 | $0.2 | $70683.5 | $(69721.2) | $(116.0) | $846.5 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** |
| | **Common Stock** | **Common Stock** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| **Balance at December 28, 2024** | 222.1 | $0.2 | $70493.0 | $(69655.6) | $(154.8) | $682.8 |
| Net income |  |  |  | 19.5 |  | 19.5 |
| Other comprehensive income |  |  |  |  | 13.9 | 13.9 |
| Shares issued under employee stock plans, net of tax | 1.1 |  | (1.5) |  |  | (1.5) |
| Stock-based compensation |  |  | 14.1 |  |  | 14.1 |
| **Balance at March 29, 2025** | 223.2 | $0.2 | $70505.6 | $(69636.1) | $(140.9) | $728.8 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** |
| | **Common Stock** | **Common Stock** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| **Balance at June 28, 2025** | 223.2 | $0.2 | $70517.9 | $(69628.1) | $(109.8) | $780.2 |
| Net loss |  |  |  | (63.1) |  | (63.1) |
| Other comprehensive loss |  |  |  |  | (6.2) | (6.2) |
| Shares issued under employee stock plans, net of tax | 3.7 |  | (16.5) |  |  | (16.5) |
| Stock-based compensation |  |  | 41.4 |  |  | 41.4 |
| Repurchase of common stock | (2.7) |  |  | (30.0) |  | (30.0) |
| Convertible note extinguishment (Note 11) | 9.7 |  | 140.7 |  |  | 140.7 |
| **Balance at March 28, 2026** | 233.9 | $0.2 | $70683.5 | $(69721.2) | $(116.0) | $846.5 |

---

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** |
| | **Common Stock** | **Common Stock** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Loss** | **Total** |
| **Balance at June 29, 2024** | 221.9 | $0.2 | $70471.9 | $(69646.5) | $(144.0) | $681.6 |
| Net income |  |  |  | 26.8 |  | 26.8 |
| Other comprehensive income |  |  |  |  | 3.1 | 3.1 |
| Shares issued under employee stock plans, net of tax | 3.3 |  | (7.1) |  |  | (7.1) |
| Stock-based compensation |  |  | 40.5 |  |  | 40.5 |
| Repurchase of common stock | (2.0) |  | 0.3 | (16.4) |  | (16.1) |
| **Balance at March 29, 2025** | 223.2 | $0.2 | $70505.6 | $(69636.1) | $(140.9) | $728.8 |

---

*The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.*

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS** |

---

**Note 1. Basis of Presentation**

The financial information for Viavi Solutions Inc. (VIAVI, also referred to as the Company, we, our and us) for the three and nine months ended March 28, 2026 and March 29, 2025 is unaudited and includes all normal and recurring adjustments the Company's management considers necessary for a fair statement of the financial information set forth herein. The accompanying Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, such information does not include all of the information and footnotes required by U.S. GAAP for annual Consolidated Financial Statements. For further information please refer to the Consolidated Financial Statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended June 28, 2025.

There have been no material changes to the Company's accounting policies during the three and nine months ended March 28, 2026 as compared to the significant accounting policies presented in "Note 1. Basis of Presentation" of the Notes to the Consolidated Financial Statements included in the Company's Annual Report for the year ended June 28, 2025 on Form 10-K, filed with the SEC on August 11, 2025.

The Consolidated Balance Sheet as of June 28, 2025 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The results for the three and nine months ended March 28, 2026 and March 29, 2025 may not be indicative of results for the fiscal year ending June 27, 2026 or any future periods.

<u>Fiscal Years</u>

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company's fiscal 2026 is a 52-week year ending on June 27, 2026. The Company's fiscal 2025 was a 52-week year ending on June 28, 2025.

<u>Principles of Consolidation</u>

The Consolidated Financial Statements include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

<u>Use of Estimates</u>

The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of net revenue and expense and the disclosure of commitments and contingencies during the reporting periods. Estimates are based on historical factors, current circumstances and the experience and judgment of management. Under changed conditions, the Company's reported financial position or results of operations may be materially impacted when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more readily available information.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 2. Recently Issued Accounting Pronouncements**

<u>Accounting Standards Issued But Not Yet Adopted</u>

In December 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2025-10, *Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities*, which provides guidance for a government grant received by a business entity. This guidance is effective for fiscal years beginning after December 15, 2028 (fiscal 2030 for the Company), and interim periods within those annual reporting periods, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.

In July 2025, the FASB issued ASU 2025-05, *Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets*, which provides a practical expedient related to the estimation of expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606: *Revenue from Contracts with Customers*, including those assets acquired in a business combination. The practical expedient permits an entity to assume that current conditions as of the balance sheet date do not change for the remaining life of the current accounts receivable and current contract assets. This guidance is effective for fiscal years beginning after December 15, 2025 (fiscal 2027 for the Company), and interim periods within those annual reporting periods, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.

In November 2024, the FASB issued ASU 2024-03, *Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires disaggregated disclosure of income statement expenses for public business entities. The objective of this guidance is to improve the disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization and depletion) in commonly presented expense captions such as Cost of revenues, Research and development (R&D) and Selling, general and administrative (SG&A). This guidance is effective for fiscal years beginning after December 15, 2026 (fiscal 2028 for the Company), and interim periods within fiscal years beginning after December 15, 2027, with early and retrospective adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.

In December 2023, the FASB issued ASU 2023-09, *Improvements to Income Tax Disclosures (Topic 740),* to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for annual periods beginning after December 15, 2024 (fiscal 2026 for the Company). The Company expects to adopt the guidance on a prospective basis for the fiscal year ending June 27, 2026, and the adoption is anticipated to result in expanded disclosures in the Company's annual financial statements.

In October 2023, the FASB issued ASU 2023-06, *Disclosure Improvements-Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative*. The amendments clarify or improve disclosure and presentation requirements on various disclosure areas, including the statement of cash flows, earnings per share, debt, equity and derivatives. The amendments will align the requirements in the FASB Accounting Standards Codification (ASC) with the SEC's regulations. The amendments in this ASU will be effective on the date the related disclosures are removed from Regulation S-X or Regulation S-K by the SEC, and will not be effective if the SEC has not removed the applicable disclosure requirement by June 30, 2027. This ASU is not expected to have a material impact on our Consolidated Financial Statements or related disclosures.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 3. Earnings Per Share**

The following table sets forth the computation of basic and diluted net income (loss) per share (*in millions, except per share data*):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $6.4 | $19.5 | $(63.1) | $26.8 |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Weighted-average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 232.0 | 222.6 | 226.2 | 222.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted shares - Convertible Notes | 9.9 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities from stock-based compensation plans | 7.6 | 4.3 |  | 3.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 249.5 | 226.9 | 226.2 | 225.2 |
| Net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.03 | $0.09 | $(0.28) | $0.12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.03 | $0.09 | $(0.28) | $0.12 |

---

In periods where the Company recognized a net loss, the impact of potentially dilutive outstanding stock-based awards and the "in-the money" conversion benefit feature above the conversion price of the 1.625% Senior Convertible Notes due 2026 (2026 Notes) and 0.625% Senior Convertible Notes due 2031 (2031 Notes) of $13.19 and $13.79 per share, respectively, have been excluded from the calculation of diluted loss per share as their inclusion would have an antidilutive effect.

The following table represents potential common shares that were not included in the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Restricted stock units |  |  | 0.6 | 1.2 |

---

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 4. Accumulated Other Comprehensive Loss**

The Company's accumulated other comprehensive loss consists of the accumulated net unrealized gains or losses on available-for-sale investments, foreign currency translation adjustments and change in unrealized components of defined benefit obligations.

For the nine months ended March 28, 2026, the changes in accumulated other comprehensive loss, net of tax, by component were as follows (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Unrealized losses on available-for sale investments** | **Foreign currency translation adjustments** | **Change in unrealized components of defined benefit obligations** | **Total** |
| Beginning balance as of June 28, 2025 | $(5.3) | $(97.5) | $(7.0) | $(109.8) |
| &nbsp;&nbsp;&nbsp;Other comprehensive loss |  | (6.3) |  | (6.3) |
| &nbsp;&nbsp;&nbsp;Amounts reclassified out of accumulated other comprehensive loss |  |  | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;Net current-period other comprehensive (loss) income |  | (6.3) | 0.1 | (6.2) |
| Ending balance as of March 28, 2026 | $(5.3) | $(103.8) | $(6.9) | $(116.0) |

---

**Note 5. Acquisitions** 

<u>High-speed Ethernet, Network Security and Channel Emulation Testing Business</u>

On October 16, 2025, the Company acquired Spirent Communications plc's (Spirent) high-speed ethernet, network security and channel emulation testing business (collectively, the HSE and CE business) from Keysight Technologies, Inc. (Keysight). The transaction provides a complementary addition to VIAVI's ethernet testing platform within its Network and Service Enablement (NSE) segment.

The cash consideration paid at closing of $399.3 million is subject to final net working capital adjustments. The acquisition met the definition of a business and has been accounted for in accordance with the authoritative guidance on business combinations; therefore, the tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the acquisition date. Acquisition related costs incurred were approximately $20.6 million, of which $11.4 million was incurred in fiscal 2026, and were recorded within SG&A in the Consolidated Statements of Operations.

The total purchase consideration was allocated to tangible and intangible assets acquired and liabilities assumed based on the preliminary fair value on the acquisition date. The Company elected to apply both practical expedients permitted under ASU No. 2021-08, *Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,* in measuring contract assets and contract liabilities acquired in the acquisition. Specifically, we have elected the practical expedient that permits an entity to reflect the aggregate effect of all modifications (on a contract-by-contract basis) as if they occurred on the acquisition date. In addition, the Company elected to determine the standalone selling prices of performance obligations as of the acquisition date, rather than at contract inception, for purpose of allocating transaction consideration.

The Company is in the process of obtaining additional information to refine its preliminary fair value estimates related to certain acquired assets and assumed liabilities. We may revise the preliminary purchase price allocation during the remainder of the measurement period as additional information becomes available. Any such revisions or changes may be material. We expect to finalize the purchase price allocation by the end of fiscal 2026.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

The following table presents the preliminary allocation of the purchase price (*in millions*):

---

| | |
|:---|:---|
| | **Amount** |
| Inventory, net | $7.7 |
| Prepayments and other current assets | 1.0 |
| Property, plant and equipment, net | 2.9 |
| Goodwill<sup>(1)</sup> | 111.6 |
| Identified intangible assets acquired | 314.2 |
| Other non-current assets | 1.7 |
| Deferred revenue<sup>(2)</sup> | (25.7) |
| Accrued payroll and related expenses | (0.8) |
| Other current liabilities | (3.9) |
| Other non-current liabilities<sup>(3)</sup> | (9.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total purchase consideration | $399.3 |

---

(1)Goodwill at acquisition date of $111.3 million increased by $0.3 million for measurement period adjustments.

(2)Represents the current portion of deferred revenue.

(3)Includes long-term deferred revenue of $8.2 million.

The Company valued the customer relationships using the multi-period excess earnings method under the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by the customer relationships. Significant assumptions related to customer relationships included (i) projected revenues, (ii) discount rate, (iii) income tax rate and (iv) customer attrition rate.

Developed technology relates to products used for our lab and production and wireless solutions. The Company valued the developed technology using the relief-from-royalty method under the income approach. This method is based on the application of a royalty rate to forecasted revenue from the developed technology. Significant assumptions related to developed technology included (i) royalty rate, (ii) projected revenues, (iii) discount rate, (iv) income tax rate and (v) technology obsolescence rate.

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition (*in millions, except useful life*):

---

| | | |
|:---|:---|:---|
| | **Estimated Useful Life** | **Amount** |
| Customer relationship | 9 years | $162.3 |
| Developed technology | 5 years | 134.8 |
| Backlog | 2 years | 10.1 |
| Trade name | 6 years | 7.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total identifiable assets acquired |  | $314.2 |

---

Goodwill represents the excess of the preliminary estimated purchase consideration over the preliminary estimates of the fair value of the net tangible and intangible assets acquired and has been allocated to the NSE segment. Goodwill is primarily attributable to expected synergies in the acquired technologies that may be leveraged by the Company in future solution offerings. The goodwill recognized is deductible for U.S. income tax purposes.

The Company has included the financial results of Spirent's HSE and CE business in its Consolidated Financial Statements from the date of acquisition. Pro forma results of operations have not been presented because the effect of the acquisition was not material to the Consolidated Statements of Operations.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

<u>Inertial Labs, Inc.</u>

On January 28, 2025, the Company acquired all of the equity of Inertial Labs, Inc. (Inertial Labs), a privately held company which specializes in resilient positioning, navigation and timing (PNT) solutions for aerospace, defense and industrial applications. The acquisition enables the Company to further broaden its solutions offering into the rapidly developing PNT landscape.

The total purchase consideration included approximately $134.4 million paid in cash at closing and additional contingent consideration of up to $175.0 million, payable upon the achievement of certain revenue targets over the course of a four-year period beginning in January 2025. As of the acquisition date, the fair value of the contingent consideration was $116.2 million. The net cash paid for the acquisition, with purchase price adjustment, was $121.6 million, which reflects the cash paid less cash acquired of $16.5 million. From the contingent consideration of $175.0 million, $3.4 million was set aside for the payment of retention bonuses over the four-year earn-out period to key personnel and service providers, contingent on continued service to the Company. Any forfeited amount will be removed from the retention bonus pool and re-distributed to the shareholders of Inertial Labs upon the achievement of the earn-out targets. The portion of the estimated fair value of the earn-out liability allocated to the retention bonuses will be accounted for as post combination expense over the requisite service period.

The cash consideration paid at closing included an escrow payment of $1.0 million subject to final net working capital adjustments. The Company paid $3.7 million in our fourth fiscal quarter of 2025 comprised of the net working capital holdback of $3.0 million and $0.7 million of the purchase price adjustment of $1.4 million. The remainder of the purchase price adjustment of $0.7 million was paid in the first quarter of fiscal 2026 and refund of prepaid tax of $0.6 million is expected to be paid in calendar 2026. In addition, the Company held back $15.0 million for indemnity claims. During the three months ended March 28, 2026, the indemnity holdback amount was reduced by $1.1 million from noncash financing activities. The acquisition met the definition of a business and has been accounted for in accordance with the authoritative guidance on business combinations; therefore, the tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the acquisition date. Acquisition related costs incurred in fiscal 2025 were approximately $11.7 million and were recorded within SG&A in the Consolidated Statements of Operations. These costs included $9.5 million in transaction bonuses that were paid at closing to key personnel and service providers of Inertial Labs.

The total purchase consideration was allocated to tangible and intangible assets acquired and liabilities assumed based on the fair value on the acquisition date. The following table presents the allocation of the purchase price (*in millions*):

---

| | |
|:---|:---|
| | **Amount** |
| Cash and cash equivalents | $16.5 |
| Accounts receivable, net | 8.1 |
| Inventory, net | 26.0 |
| Prepayments and other current assets | 1.1 |
| Property, plant and equipment, net | 1.9 |
| Goodwill<sup>(1)</sup> | 130.3 |
| Identified intangible assets acquired | 117.6 |
| Other non-current assets | 1.9 |
| Accounts payable | (1.4) |
| Accrued payroll and related expenses | (0.5) |
| Deferred revenue | (0.3) |
| Accrued expenses | (3.5) |
| Other non-current liabilities<sup>(2)</sup> | (27.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total purchase consideration | $270.6 |

---

(1)Goodwill at acquisition date of $129.7 million increased by $0.6 million for purchase price and measurement period adjustments.

(2)Includes $25.0 million of deferred tax liability and $0.9 million of liability related to uncertain tax positions.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

Developed technology relates to products used for PNT solutions for aerospace, defense and industrial applications. The Company valued the developed technology using the multi-period excess earnings method under the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by the developed technology. Significant assumptions used in the discounted cash flow analysis include (i) projected revenues, (ii) discount rate, and (iii) technology obsolescence rate.

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition (*in millions, except useful life*):

---

| | | |
|:---|:---|:---|
| | **Estimated Useful Life** | **Amount** |
| Developed technology | 4 to 7 years | $102.0 |
| Customer relationship | 6 years | 9.6 |
| Tradename | 3 years | 0.8 |
| Backlog | 2 years | 5.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total identifiable assets acquired |  | $117.6 |

---

Goodwill represents the excess of the purchase consideration over the fair value of the net tangible and intangible assets acquired and has been allocated to the NSE segment. Goodwill is primarily attributable to expected synergies in the acquired technologies that may be leveraged by the Company in future PNT offerings. None of the goodwill recognized is deductible for U.S. income tax purposes.

The Company has included the financial results of Inertial Labs in its Consolidated Financial Statements from the date of acquisition. Pro forma results of operations have not been presented because the effect of the acquisition was not material to the Consolidated Statements of Operations.

<u>Jackson Labs Technologies, LLC</u>

On October 5, 2022, the Company acquired all of the equity of Jackson Labs Technologies, LLC (Jackson Labs), a privately held company which specializes in PNT solutions for critical infrastructure serving both military and civilian applications. The acquisition enables the Company to broaden its solutions offering into the rapidly developing PNT landscape. The total purchase consideration included approximately $49.9 million paid in cash at closing and additional contingent consideration of up to $117.0 million.

<u>Acquisition related Contingent Consideration</u>

Refer to "Note 8. Fair Value Measurements" for information on the contingent consideration activity for the three and nine months ended March 28, 2026.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 6. Balance Sheet and Other Details** 

<u>Contract Balances</u>

Gross receivables include both billed and unbilled receivables (including Contract assets). As of March 28, 2026 and June 28, 2025, the Company had total unbilled receivables of $17.2 million and $14.1 million.

The Company also has short-term and long-term deferred revenues related to undelivered product and professional services, consisting of installations and consulting engagements, which are recognized as the Company's performance obligations under the contract are completed and accepted by the customer.

The following table presents the activity related to deferred revenue (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **March 28, 2026** |
| | **Three Months Ended** | **Nine Months Ended** |
| **Deferred revenue:** | | |
| Balance at beginning of period | $118.3 | $102.3 |
| Revenue deferrals for new contracts<sup>(1)</sup> | 43.2 | 94.8 |
| Acquisition<sup>(2)</sup> | 0.4 | 33.9 |
| Revenue recognized during the period<sup>(3)</sup> | (40.2) | (109.3) |
| Balance at end of period | $121.7 | $121.7 |

---

(1)This amount includes the effect of foreign currency exchange rate fluctuations.

(2)This amount includes deferred revenue at acquisition date and measurement period adjustments. Refer to "Note 5. Acquisitions" for more information.

(3)Revenue recognized during the period represents releases from the balance at the beginning of the period as well as releases from the current period deferrals including the acquired deferred revenue.

Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, adjustments for revenue that have not materialized, and currency fluctuations.

The value of the transaction price allocated to remaining performance obligations as of March 28, 2026, was $533.8 million. The Company expects to recognize approximately 92% of remaining performance obligations as revenue within the next 12 months, and the remainder thereafter.

<u>Accounts receivable allowances - Credit losses</u>

The following table presents the activities and balances for allowance for credit losses (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **June 28, 2025** | **Charged to Costs and Expenses** | **Deductions**<sup>(1)</sup> | **March 28, 2026** |
| Allowance for credit losses | $1.9 | $1.2 | $(0.6) | $2.5 |

---

(1)Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

<u>Inventories, net</u>

The following table presents the components of inventories, net (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Finished goods | $61.2 | $52.5 |
| Work in process | 21.2 | 18.3 |
| Raw materials | 65.5 | 47.1 |
| &nbsp;&nbsp;&nbsp;Inventories, net | $147.9 | $117.9 |

---

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

<u>Prepayments and other current assets</u>

The following table presents the components of prepayments and other current assets (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Refundable income taxes | $24.7 | $32.0 |
| Prepayments | 18.3 | 21.9 |
| Advances to contract manufacturers | 15.5 | 5.8 |
| Fair value of forward contracts | 1.4 | 4.9 |
| Other current assets | 17.6 | 12.7 |
| &nbsp;&nbsp;&nbsp;Prepayments and other current assets | $77.5 | $77.3 |

---

<u>Other non-current assets</u>

The following table presents the components of other non-current assets (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Operating right-of-use (ROU) assets | $41.9 | $34.1 |
| Long-term restricted cash | 5.1 | 4.9 |
| Long-term investment (Note 7) | 3.0 | 3.0 |
| Deferred contract cost | 2.9 | 3.0 |
| Debt issuance cost - Revolving Credit Facility | 2.7 | 1.4 |
| Deposits | 2.5 | 2.4 |
| Other | 14.0 | 13.4 |
| &nbsp;&nbsp;&nbsp;Other non-current assets | $72.1 | $62.2 |

---

<u>Other current liabilities</u>

The following table presents the components of other current liabilities (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Fair value of contingent consideration (Note 8) | $43.0 | $41.5 |
| Acquisition related holdback and related accruals | 16.5 | 16.5 |
| Restructuring accrual (Note 13) | 16.5 | 3.5 |
| Interest payable | 13.4 | 5.1 |
| Operating lease liabilities | 11.5 | 10.2 |
| Income tax payable | 8.0 | 8.2 |
| Warranty accrual | 6.7 | 5.9 |
| Fair value of forward contracts | 2.1 | 3.1 |
| Other | 22.8 | 14.3 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | $140.5 | $108.3 |

---

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

<u>Other non-current liabilities</u>

The following table presents components of other non-current liabilities (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Pension and post-employment benefits | $51.2 | $54.1 |
| Long-term deferred revenue | 36.6 | 28.2 |
| Operating lease liabilities | 30.6 | 24.1 |
| Fair value of contingent consideration (Note 8) | 25.2 | 75.9 |
| Financing obligation | 13.6 | 15.5 |
| Uncertain tax position | 11.9 | 11.4 |
| Deferred tax liability | 10.1 | 6.0 |
| Asset retirement obligations | 3.9 | 3.5 |
| Warranty accrual |  | 0.8 |
| Other | 9.4 | 8.1 |
| &nbsp;&nbsp;&nbsp;Other non-current liabilities | $192.5 | $227.6 |

---

**Note 7. Investments and Forward Contracts** 

<u>Short-Term Investments</u>

As of March 28, 2026, the Company's short-term investments of $1.8 million were primarily related to the deferred compensation plan, of which $1.7 million was invested in equity securities.

As of June 28, 2025, the Company's short-term investments of $1.7 million were primarily related to the deferred compensation plan, of which $1.6 million was invested in equity securities.

Trading securities are reported at fair value, with unrealized gains or losses resulting from changes in fair value recognized in the Consolidated Statements of Operations as a component of Interest and other income, net.

<u>Strategic Investment</u>

During fiscal 2025, the Company invested $3.0 million in a non-marketable equity security in a privately held company. The investment is included in Other non-current assets on our Consolidated Balance Sheets and is classified as Level 3 within the fair value hierarchy.

This investment is carried at cost and because the investment does not have a readily determinable fair value it will be adjusted for changes resulting from observable price changes under the Measurement Alternative methodology. There were no impairments or adjustments to the carrying value for the three and nine months ended March 28, 2026.

<u>Equity Investment</u>

The Company acquired an equity interest in Sensorsan Sensor Teknolojileri Anonim Sirketi (Sensorsan), a privately held entity and owns 40% percent of Sensorsan, through its acquisition of Inertial Labs.

The Company accounts for its investment in Sensorsan under the equity method of accounting. Under the equity method, the Company recognizes income or loss from its pro-rata share of Sensorsan's net income or loss, which changes the carrying value of the Sensorsan investment.

The Company's share of Sensorsan's net income for the nine months ended March 28, 2026 was $0.2 million. As of March 28, 2026 and June 28, 2025, the carrying value of the Company's investment in Sensorsan was $1.4 million and $1.3 million, respectively, included in Other non-current assets on the Consolidated Balance Sheets. The Company sells certain products to Sensorsan. During the three and nine months ended March 28, 2026, revenue from sales to Sensorsan was $0.9 million and $2.1 million, respectively.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

<u>Non-Designated Foreign Currency Forward Contracts</u>

The Company has foreign subsidiaries that operate and sell the Company's products in various markets around the world. As a result, the Company is exposed to foreign exchange risks. The Company utilizes foreign exchange forward contracts to manage foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables, and to reduce the volatility of earnings and cash flows related to foreign currency transactions. The Company does not use these foreign currency forward contracts for trading purposes.

As of March 28, 2026, the Company had forward contracts that were effectively closed but not settled with the counterparties as of the balance sheet date. Therefore, the fair value of these contracts of $1.4 million and $2.1 million is reflected as Prepayments and other current assets and Other current liabilities on the Consolidated Balance Sheets, respectively. As of June 28, 2025, the fair value of these contracts of $4.9 million and $3.1 million is reflected as Prepayments and other current assets and Other current liabilities on the Consolidated Balance Sheets, respectively.

The forward contracts outstanding and not effectively closed, with a term of less than 120 days, were transacted near quarter end; therefore, the fair value of the contracts is not significant. As of March 28, 2026 and June 28, 2025, the notional amounts of the forward contracts that the Company held to purchase foreign currencies were $59.3 million and $60.4 million, respectively, and the notional amounts of forward contracts that the Company held to sell foreign currencies were $48.4 million and $24.1 million, respectively.

The change in the fair value of these foreign currency forward contracts is recorded as gain or loss in the Consolidated Statements of Operations as a component of Interest and other income, net. The cash flows related to the settlement of foreign currency forward contracts are classified as operating activities. The foreign exchange forward contracts incurred losses of $0.7 million and $0.3 million for the three and nine months ended March 28, 2026, respectively, and incurred a gain of $0.5 million and a loss of $2.8 million for the three and nine months ended March 29, 2025.

**Note 8. Fair Value Measurements** 

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs which market participants would use in valuing an asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs which reflect the assumptions market participants would use in valuing an asset or liability.

The three levels of inputs that may be used to measure fair value are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: includes financial instruments for which quoted market prices for identical instruments are available in active markets. Level 1 assets of the Company include money market funds, U.S. Treasury securities and marketable equity securities as they are traded with sufficient volume and frequency of transactions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: includes financial instruments for which the valuations are based on quoted prices for similar assets or liabilities in active markets, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 2 instruments of the Company include asset-backed securities, foreign currency forward contracts and debt. To estimate their fair value, the Company utilizes pricing models based on market data. The significant inputs for the valuation model usually include benchmark yields, reported trades, broker and dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data, and industry and economic events.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: includes financial instruments for which fair value is derived from valuation-based inputs, that are unobservable and significant to the overall fair value measurement. The Company's Level 3 assets consist of an investment in a non-marketable equity security in a privately held company. We measure the non-marketable equity security under the Measurement Alternative at cost minus impairment, if any, adjusted to fair value only if an observable price change in orderly transactions for an identical or similar investment occurs for the same issuer. The Company's Level 3 liabilities consist of contingent purchase consideration liabilities related to business acquisitions. The fair value of such earn-out liabilities are generally determined using a Monte Carlo Simulation that includes significant unobservable inputs such as the projected revenues of the acquired business over the earn-out period. The fair value of certain earn-out liabilities is derived using the estimated probability of success of achieving the earn-out milestones discounted to present value. The fair value of contingent consideration liabilities is remeasured at each reporting period at the estimated fair value based on the inputs on the date of remeasurement, with the change in fair value recognized as a component of SG&A in the Consolidated Statements of Operations.

<u>Fair Value Measurements</u>

The following table summarizes the Company's assets and liabilities measured at fair value on a recurring basis, along with their classification by level of input for the periods presented (*in millions*):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** |
| | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| Assets: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Debt available-for-sale securities<sup>(1)</sup> | $0.3 | $— | $0.3 | $— | $0.3 | $— | $0.3 | $— |
| &nbsp;&nbsp;Money market funds<sup>(2)</sup> | 272.7 | 272.7 |  |  | 229.0 | 229.0 |  |  |
| &nbsp;&nbsp;Trading securities<sup>(3)</sup> | 1.7 | 1.7 |  |  | 1.6 | 1.6 |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts<sup>(4)</sup> | 1.4 |  | 1.4 |  | 4.9 |  | 4.9 |  |
| &nbsp;&nbsp;&nbsp;Total assets | $276.1 | $274.4 | $1.7 | $— | $235.8 | $230.6 | $5.2 | $— |
| Liabilities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts<sup>(5)</sup> | $2.1 | $— | $2.1 | $— | $3.1 | $— | $3.1 | $— |
| &nbsp;&nbsp;Contingent consideration<sup>(6)</sup> | 68.2 |  |  | 68.2 | 117.4 |  |  | 117.4 |
| &nbsp;&nbsp;&nbsp;Total liabilities | $70.3 | $— | $2.1 | $68.2 | $120.5 | $— | $3.1 | $117.4 |

---

(1)Included in Other non-current assets on the Consolidated Balance Sheets.

(2)Includes, as of March 28, 2026, $263.1 million in Cash and cash equivalents, $6.7 million in Restricted cash and $2.9 million in Other non-current assets on the Consolidated Balance Sheets. Includes, as of June 28, 2025, $222.4 million in Cash and cash equivalents, $3.5 million in Restricted cash and $3.1 million in Other non-current assets on the Consolidated Balance Sheets.

(3)Included in Short-term investments on the Consolidated Balance Sheets.

(4)Included in Prepayments and other current assets on the Consolidated Balance Sheets.

(5)Included in Other current liabilities on the Consolidated Balance Sheets.

(6)As of March 28, 2026 and June 28, 2025, includes certain amounts in Other current liabilities and Other non-current liabilities on the Consolidated Balance Sheets.

<u>Contingent Consideration</u>

As of March 28, 2026, the fair value of the contingent consideration liability for Inertial Labs was $68.2 million, compared to $139.1 million at December 27, 2025 and $117.1 million at June 28, 2025. As of March 28, 2026, $43.0 million and $25.2 million of the liability are included in Other current liabilities and Other non-current liabilities, respectively, on the Consolidated Balance Sheets. During the three months ended March 28, 2026, the Company made a contingent consideration payment of $73.5 million for Inertial Labs, of which acquisition date fair value of $29.8 million was classified as a financing outflow and the remaining classified as an operating activity within Accrued expenses and other current and non-current liabilities in the Consolidated Statements of Cash Flows.

The earn-out period for Jackson Labs ended on December 31, 2025. The Company was not required to make a contingent consideration payment as the revenue targets were not met.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

The Company recorded charges of $2.6 million and $24.3 million, respectively, from the change in fair value measurement of the contingent consideration liabilities within SG&A in the Consolidated Statements of Operations for the three and nine months ended March 28, 2026.

<u>Instrument Measured at Fair Value on Non-recurring Basis</u>

Our non-marketable equity security accounted for using the Measurement Alternative is measured at fair value on a non-recurring basis and is classified within Level 3 of the fair value hierarchy because we use significant unobservable inputs to estimate its fair value. Refer to "Note 7. Investments and Forward Contracts" for additional information.

<u>Other Fair Value Measures</u>

Fair Value of Debt: If measured at fair value on the Consolidated Balance Sheets, the Company's 0.625% Senior Convertible Notes (2031 Notes), 3.75% Senior Notes (2029 Notes), 1.625% Senior Convertible Notes (2026 Notes) and Term Loan B would be classified in Level 2 of the fair value hierarchy as they are not actively traded in the markets. The Company's debt measured at fair value for the periods presented is as follows (*in millions*):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** |
| | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| Debt: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;0.625% Senior Convertible Notes | $648.2 | $— | $648.2 | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;3.75% Senior Notes | 370.7 |  | 370.7 |  | 373.6 |  | 373.6 |  |
| &nbsp;&nbsp;1.625% Senior Convertible Notes<sup>(1)</sup> |  |  |  |  | 252.0 |  | 252.0 |  |
| &nbsp;&nbsp;&nbsp;Term Loan B | 452.3 |  | 452.3 |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Total | $1471.2 | $— | $1471.2 | $— | $625.6 | $— | $625.6 | $— |

---

(1) The 2026 Notes were settled upon maturity on March 15, 2026. See "Note 11. Debt", for further discussion of the Company's debt.

**Note 9. Goodwill** 

The following table presents changes in goodwill allocated to the Company's reportable segments *(in millions)*:

---

| | | | |
|:---|:---|:---|:---|
| | **Network and Service Enablement** | **Optical Security and Performance Products** | **Total** |
| Balance as of June 28, 2025 | $553.5 | $42.2 | $595.7 |
| Acquisition<sup>(1)</sup> | 111.3 |  | 111.3 |
| Measurement period adjustments<sup>(1)</sup> | 0.3 |  | 0.3 |
| Currency translation | (5.5) |  | (5.5) |
| Balance as of March 28, 2026 | $659.6 | $42.2 | $701.8 |

---

(1)Goodwill at acquisition date and adjustments. Refer to "Note 5. Acquisitions" for more information.

The Company tests goodwill for impairment at the reporting unit level annually during the fourth quarter of each fiscal year, or more frequently if events or circumstances indicate that the asset may be impaired. In the fourth quarter of fiscal 2025, the Company performed a qualitative assessment of goodwill impairment and concluded that it was more likely than not that the fair value of each reporting unit exceeded its carrying amount and that no indication of impairment existed.

There were no events or changes in circumstances that triggered an impairment review during the three and nine months ended March 28, 2026.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 10. Intangibles** 

The following tables present details of the Company's acquired developed technology, customer relationships and other intangibles as of March 28, 2026 and June 28, 2025 (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>As of March 28, 2026</u>** | **Weighted-Average Remaining Useful Life** | **Gross Carrying Amount** | **Accumulated Amortization** | **Net** |
| Acquired developed technology | *4.7 years* | $667.9 | $(448.8) | $219.1 |
| Customer relationships | *8.3 years* | 369.3 | (207.3) | 162.0 |
| Other<sup>(1)</sup> | *3.0 years* | 60.6 | (43.7) | 16.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total intangibles |  | $1097.8 | $(699.8) | $398.0 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>As of June 28, 2025</u>** | **Weighted-Average Remaining Useful Life** | **Gross Carrying Amount** | **Accumulated Amortization** | **Net** |
| Acquired developed technology | *5.5 years* | $534.5 | $(417.7) | $116.8 |
| Customer relationships | *5.2 years* | 209.0 | (199.1) | 9.9 |
| Other<sup>(1)</sup> | *1.7 years* | 44.1 | (39.2) | 4.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total intangibles |  | $787.6 | $(656.0) | $131.6 |

---

(1)Other intangibles consist of proprietary know-how and trade secrets, trademarks and trade names.

Amortization expense related to intangibles was $20.4 million and $7.3 million for the three months ended March 28, 2026 and March 29, 2025, respectively, and $47.6 million and $16.0 million for the nine months ended March 28, 2026 and March 29, 2025, respectively.&nbsp;&nbsp;&nbsp;&nbsp;

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of March 28, 2026, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (*in millions*):

---

| | |
|:---|:---|
| **<u>Fiscal Years</u>** | |
| Remainder of 2026 | $20.2 |
| 2027 | 77.7 |
| 2028 | 67.9 |
| 2029 | 63.5 |
| 2030 | 62.4 |
| Thereafter | 106.3 |
| Total amortization | $398.0 |

---

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 11. Debt**

As of March 28, 2026 and June 28, 2025, the Company's debt on the Consolidated Balance Sheets, net of unamortized debt discount and issuance costs, is as follows (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Principal amount of 0.625% Senior Convertible Notes | $250.0 | $— |
| Unamortized 0.625% Senior Convertible Notes debt issuance cost | (5.5) |  |
| Principal amount of 1.625% Senior Convertible Notes |  | 250.0 |
| Unamortized 1.625% Senior Convertible Notes debt discount |  | (3.3) |
| Unamortized 1.625% Senior Convertible Notes debt issuance cost |  | (0.5) |
| Short-term debt | $244.5 | $246.2 |
| Principal amount of 3.75% Senior Notes | $400.0 | $400.0 |
| Unamortized 3.75% Senior Notes debt issuance cost | (3.1) | (3.7) |
| Principal amount of Term Loan B | 450.0 |  |
| Unamortized Term Loan B debt issuance cost | (10.6) |  |
| Long-term debt | $836.3 | $396.3 |

---

The Company was in compliance with all debt covenants as of March 28, 2026 and June 28, 2025.

<u>Term Loan B</u>

On October 16, 2025, concurrent with the closing of the acquisition of Spirent's HSE and CE business, the Company entered into a $600 million senior secured term loan credit agreement (Term Loan Credit Agreement) with Wells Fargo Bank, National Association (Wells Fargo), as administrative agent, and other lenders. The term loans, which mature on October 16, 2032, are secured by substantially all of the assets of the Company and those of its domestic subsidiaries. The proceeds from the term loans were used to finance a portion of the acquisition, acquisition related expenses and will be used for general corporate purposes. In connection with the issuance of the term loans, the Company incurred $15.2 million of issuance costs. The debt issuance costs were capitalized in Long-term debt on the Consolidated Balance Sheets and will be amortized to interest expense using the straight-line method until maturity. The term loans bear interest at rates based on Term Secured Overnight Financing Rate (SOFR) or a specified base rate plus applicable margins with interest payment frequency at the Company's election. The term loans require quarterly principal payments of 1.0% per annum, commencing on March 31, 2026. The Company may prepay all or part of the term loans early at its option.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

The covenants of the Term Loan Credit Agreement include customary restrictive covenants that, among other things, restrict the Company's ability to incur additional indebtedness, grant liens, make certain acquisitions, investments, asset dispositions and restricted payments, undertake fundamental changes and enter into restrictive agreements, in each case subject to certain exceptions. The Term Loan Credit Agreement includes customary events of default, and customary rights and remedies upon the occurrence of any event of default thereunder, including rights to accelerate the loans and realize upon the collateral securing the obligations under the Term Loan Credit Agreement and any related guarantees thereof.

On January 5, 2026, and March 4, 2026, the Company made prepayments of $100.0 million and $50.0 million, respectively, of the term loans under the Term Loan Credit Agreement. The prepayments were accounted for as partial extinguishments, with the carrying amount of the portion of debt prepaid, including the proportionate unamortized debt issuance costs, derecognized, and any difference between the reacquisition price and the carrying amount recognized as a loss on debt extinguishment. The Company recorded a loss of $3.7 million within Loss on debt extinguishment in the Consolidated Statements of Operations.

With these prepayments, VIAVI is no longer required to make quarterly principal payments of 1.0% per annum since the prepayments exceeded the total required amortization over the life of the loan.

As of March 28, 2026, the interest rate for the borrowings under the term loans was 6.17%, which approximated the effective interest rate and the expected remaining term is 6.6 years.

<u>0.625% Senior Convertible Notes (2031 Notes)</u>

On August 20, 2025, the Company issued $250.0 million aggregate principal amount of 0.625% Senior Convertible Notes due 2031 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company issued $100.9 million aggregate principal amount of the 2031 Notes to certain holders of the 1.625% Senior Convertible Notes (2026 Notes) in exchange for $97.5 million principal amount of the 2026 Notes (the 2025 Exchange Transaction) and issued and sold $149.1 million aggregate principal amount of the 2031 Notes in a private placement to accredited institutional buyers (the 2025 Subscription Transactions).

The 2025 Exchange Transaction was accounted for as an extinguishment which resulted in the write-off of unamortized debt discount and issuance costs of $1.1 million on the extinguished notes. Accrued interest of $0.7 million on the 2026 Notes was included in the exchange for the 2031 Notes. The total loss from the exchange was $3.8 million recorded as Loss on debt extinguishment in the Consolidated Statements of Operations.

Concurrent with the transactions discussed above, the Company repurchased and subsequently retired 2.7 million shares of its common stock for $30.0 million under the 2022 Repurchase Plan.

In connection with the issuance of the 2031 Notes, the Company incurred $6.1 million of issuance costs. The debt issuance costs were capitalized and will be amortized to interest expense using the straight-line method until maturity.

The 2031 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 0.625%, payable semi-annually in arrears on March 1 and September 1 of each year, beginning March 1, 2026. The 2031 Notes will mature on March 1, 2031 unless earlier converted, redeemed or repurchased.

The 2031 Notes may be converted under certain circumstances, based on an initial conversion rate of 72.5295 shares (equivalent to an initial conversion price of approximately $13.79 per share) at the option of the holders into cash up to the principal amount, with the remaining amount converted into cash, shares of the Company's common stock, or a combination of cash and shares of the Company's common stock at the Company's election. The initial conversion price represents a 25.0% premium to the closing price of the Company's common stock on the pricing date, August 13, 2025, which will be subject to customary anti-dilution adjustments.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

During the third quarter of fiscal 2026, the closing price of the Company's common stock exceeded 130% of the applicable conversion price of the 2031 Notes, on at least 20 of the last 30 consecutive trading days of the calendar quarter, causing the 2031 Notes to be convertible by their holders for the period April 1, 2026 to June 30, 2026. While the last two trading days of the calendar quarter ending March 31, 2026 were after the Balance Sheet date, the pricing trigger was met for the calendar quarter. As a result, the $244.5 million carrying value of the 2031 Notes has been reclassified to short-term debt.

As of March 28, 2026, the expected remaining term of the 2031 Notes is 4.9 years.

<u>1.625% Senior Convertible Notes (2026 Notes)</u>

On March 6, 2023, the Company issued $250.0 million aggregate principal amount of 1.625% Senior Convertible Notes due 2026 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company issued $132.0 million aggregate principal amount of the 2026 Notes to certain holders of the 1.00% Senior Convertible Notes due 2024 (2024 Notes) in exchange for $127.5 million principal amount of the 2024 Notes (the 2023 Exchange Transaction) and issued and sold $118.0 million aggregate principal amount of the 2026 Notes in a private placement to accredited institutional buyers (the 2023 Subscription Transactions).

The 2023 Exchange Transaction was accounted for as a modification. The $127.5 million principal of the 2024 Notes was reduced by $10.1 million, with offsetting increase to additional paid-in capital, to account for the increase in the fair value of the embedded conversion option in the modification. The increase in principal and coupon interest, along with the increased option value, totaled $14.6 million and is a direct reduction from the carrying amount of the debt on the Consolidated Balance Sheets. This amount has been accreted as an adjustment to interest expense on a straight-line basis up to the full face value of the 2026 Notes through maturity on March 15, 2026.

The proceeds of the 2023 Subscription Transactions amounted to $113.8 million after issuance costs of $4.2 million. The exchange resulted in $2.2 million of the issuance costs recorded as Loss on convertible note modification in the Consolidated Statements of Operations. The remaining issuance costs of $2.0 million, as well as $0.3 million of unamortized costs carried over from the 2024 Notes at the exchange date were capitalized within Long-term debt (as a contra-balance) on the Consolidated Balance Sheets and were amortized to interest expense using the straight-line method until maturity on March 15, 2026.

On August 20, 2025, as part of the 2025 Exchange Transaction, the Company exchanged $97.5 million aggregate principal amount of the 2026 Notes for $100.9 million aggregate principal amount of the 2031 Notes.

On December 15, 2025, the Company entered into separate privately-negotiated agreements with certain holders of the 2026 Notes. On December 22, 2025, the Company settled $103.5 million principal amount of 2026 Notes in exchange for an aggregate of 7.9 million shares of its common stock, par value $0.001 per share. Accrued interest was paid in cash. The transaction was accounted for as a debt extinguishment. The exchange did not qualify as an induced conversion. The Company recorded a loss on debt extinguishment of $38.7 million, representing the excess of the fair value of the shares issued over the carrying amount of the notes extinguished and transaction costs associated with the settlement. The loss is presented as Loss on debt extinguishment in the Company's Consolidated Statements of Operations.

On March 15, 2026, the outstanding $49.0 million principal amount of the 2026 Notes matured. Nearly all holders of the 2026 Notes chose to convert and the settlement of the conversion resulted in a cash payment of $49.4 million, including $49.0 million in principal and $0.4 million in accrued interest, and the issuance of 1.8 million shares of its common stock for conversion value above par.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

<u>3.75% Senior Notes (2029 Notes)</u>

On September 29, 2021, the Company issued $400.0 million aggregate principal amount of 3.75% Senior Notes due 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. In connection with the issuance of the 2029 Notes, the Company incurred $7.0 million of issuance costs. The debt issuance costs were capitalized and will be amortized to interest expense using the straight-line method until maturity. The 2029 Notes are an unsecured obligation of the Company and bear annual interest of 3.75%, payable semi-annually in arrears on April 1 and October 1 of each year, beginning April 1, 2022. The 2029 Notes will mature on October 1, 2029 unless earlier redeemed or repurchased. As of March 28, 2026, the expected remaining term of the 2029 Notes is 3.5 years.

<u>1.00% Senior Convertible Notes (2024 Notes)</u>

On March 3, 2017, the Company issued $400.0 million aggregate principal amount of 1.00% Senior Convertible Notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. On March 22, 2017, the Company issued an additional $60.0 million upon exercise of the over-allotment option of the initial purchasers. The total proceeds from the 2024 Notes amounted to $451.1 million after issuance costs of $8.9 million. The debt issuance costs were capitalized and amortized to interest expense using the straight-line method from the issuance date through maturity on March 1, 2024.

During fiscal 2022, the Company entered into separate privately-negotiated agreements with certain holders of the 2024 Notes, settling $236.1 million principal in exchange for an aggregate of 8.6 million shares of its common stock, par value $0.001 per share, and $178.8 million in cash. The 2023 Exchange Transaction resulted in the reduction of $127.5 million principal of the 2024 Notes. On March 1, 2024, the Company converted two notes at the request of the respective note-holders and retired the remaining 2024 Notes principal of $96.4 million upon maturity.

<u>Senior Secured Asset-Based Revolving Credit Facility</u>

On December 30, 2021, we entered into a credit agreement (the Credit Agreement) with Wells Fargo as administrative agent, and other lender related parties. On October 16, 2025, the Company entered into an agreement with Wells Fargo to amend and extend the Credit Agreement. The Credit Agreement, as amended, provides for a senior secured asset-based revolving credit facility in a maximum aggregate amount of $200 million and matures on October 16, 2030. The Credit Agreement also provides that, under certain circumstances, the Company may increase the aggregate amount of revolving commitments thereunder by an aggregate amount of up to $100 million so long as certain conditions are met. The proceeds from the credit facility established under the Credit Agreement will be used for working capital and other general corporate purposes. The obligations under the Credit Agreement are secured by substantially all of the assets of the Company and those of its subsidiaries that are borrowers and guarantors under the Credit Agreement.

Amounts outstanding under the Credit Agreement accrue interest as follows: (i) if the amounts outstanding are denominated in U.S. Dollars, at a per annum rate equal to either, at the Company's election, SOFR plus a margin of 1.50% to 2.00% per annum, or a specified base rate plus a margin of 0.50% to 1.00%, in each case, depending on the average excess availability under the facility, (ii) if the amounts outstanding are denominated in Sterling, at a per annum rate equal to the Sterling Overnight Interbank Average Rate (SONIA) plus a margin of 1.50% to 2.00%, depending on the average excess availability under the facility, (iii) if the amounts outstanding are denominated in Euros, at a per annum rate equal to the Euro Interbank Offered Rate plus a margin of 1.50% to 2.00%, depending on the average excess availability under the facility, or (iv) if the amounts outstanding are denominated in Canadian Dollars, at a per annum rate equal to either, at the Company's election, the adjusted Term Canadian Overnight Repo Rate Average (CORRA) plus a margin of 1.50% to 2.00%, or a specified base rate plus a margin of 0.50% to 1.00%, in each case, depending on the average excess availability under the facility.

The covenants of the Credit Agreement include customary restrictive covenants that, among other things, restrict the Company's ability to incur additional indebtedness, grant liens and make certain acquisitions, investments, asset dispositions and restricted payments. In addition, the Credit Agreement contains certain financial covenants that require the Company to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 if excess availability under the facility is less than the greater of 10% of the lesser of maximum revolver amount and borrowing base and $13.3 million.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

As of March 28, 2026, we had no borrowings under this facility and our available borrowing capacity was approximately $182.7 million, net of outstanding standby letters of credit of $3.8 million.

<u>Interest Expense</u>

The following table presents the interest expense for contractual interest, amortization of debt issuance cost, accretion of debt discount and other (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Interest expense-contractual interest | $12.1 | $4.8 | $29.4 | $14.3 |
| Amortization of debt issuance cost | 1.1 | 0.6 | 3.0 | 1.8 |
| Accretion of debt discount | 0.2 | 1.2 | 1.9 | 3.6 |
| Other | 0.9 | 0.9 | 2.7 | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | $14.3 | $7.5 | $37.0 | $22.5 |

---

**Note 12. Leases**

The Company is a lessee in several operating leases, primarily real estate facilities for office space. The Company's lease arrangements are comprised of operating leases with various expiration dates through March 31, 2042. The Company's leases do not contain any material residual value guarantees.

Lease expense and cash flow information related to our operating leases is as follows (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Operating lease costs<sup>(1)</sup> | $3.7 | $3.4 | $10.6 | $9.8 |
| Cash paid for amounts included in the measurement of operating lease liabilities | $3.8 | $3.5 | $11.1 | $9.7 |
| Operating ROU assets obtained in exchange for operating lease obligations | $6.0 | $4.4 | $16.6 | $7.1 |

---

(1)Total variable lease costs were immaterial during the three and nine months ended March 28, 2026 and March 29, 2025. The total operating lease costs were included in Cost of revenues, R&D, and SG&A in the Consolidated Statements of Operations.

As of March 28, 2026 and March 29, 2025, the weighted-average remaining lease term was 5.6 years and 6.0 years, respectively, and the weighted-average discount rate was 6.3% and 5.8%, respectively.

Future minimum operating lease payments as of March 28, 2026 are as follows (*in millions*):

---

| | |
|:---|:---|
| | **Operating Leases** |
| Remainder of fiscal 2026 | $2.1 |
| Fiscal 2027 | 13.4 |
| Fiscal 2028 | 10.7 |
| Fiscal 2029 | 7.6 |
| Fiscal 2030 | 5.2 |
| Thereafter | 11.5 |
| &nbsp;&nbsp;&nbsp;Total lease payments | 50.5 |
| Less: Interest | (8.4) |
| &nbsp;&nbsp;&nbsp;Present value of lease liabilities | $42.1 |

---

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 13. Restructuring** 

The Company's restructuring events are primarily intended to reduce costs, consolidate operations, integrate various acquisitions, streamline product manufacturing and address market conditions. Restructuring charges include severance, benefits and outplacement costs to eliminate a specified number of positions. The timing of associated cash payments is dependent upon the jurisdiction of the affected employees and can extend over multiple periods.

<u>Fiscal 2026 Plan</u>

During the third quarter of fiscal 2026, management approved a restructuring and workforce reduction plan (the Fiscal 2026 Plan) across our NSE and Optical Security and Performance Products (OSP) segments and Corporate (Corp) functions intended to improve operational efficiencies, better align the Company's workforce with current business needs and strategic growth opportunities and includes integration of recently acquired businesses. The Fiscal 2026 Plan includes a global workforce reduction, facilities rationalization and asset write-offs. The Company anticipates the Fiscal 2026 Plan to be substantially complete by the end of calendar year 2026.

During the three months ended March 28, 2026, the Company recognized restructuring charges of $17.4 million of employee severance, benefits and outplacement costs recorded within Restructuring and related charges (benefits) in the Consolidated Statements of Operations. In addition, the Company recognized Fiscal 2026 Plan charges of $3.6 million and $0.3 million related to property, plant and equipment recorded within Cost of revenues and SG&A, respectively, and $0.3 million of accelerated depreciation recorded within SG&A, each in the Consolidated Statements of Operations.

<u>Fiscal 2024 Plan</u>

During the fourth quarter of fiscal 2024, management approved a restructuring and workforce reduction plan (the Fiscal 2024 Plan) across our NSE and OSP segments and Corp functions intended to improve operational efficiencies and better align the Company's workforce with current business needs. Restructuring activity related to the OSP segment was complete during fiscal 2025. The Company anticipates the Fiscal 2024 Plan will be complete by the end of fiscal 2026.

A summary of the activity in the restructuring accrual is outlined below *(in millions)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Balance as of June 28, 2025**<sup>(1)</sup> | **Restructuring and related charges (benefits)** | **Cash settlements** | **Foreign currency translation adjustments** | **Balance as of March 28, 2026**<sup>(1)</sup> |
| **Fiscal 2026 Plan** | | | | | |
| &nbsp;&nbsp;&nbsp;*NSE/Corp* | $— | $15.6 | $(0.7) | $(0.2) | $14.7 |
| &nbsp;&nbsp;&nbsp;*OSP* |  | 1.8 | (0.2) |  | 1.6 |
| &nbsp;&nbsp;&nbsp;***Fiscal 2026 Plan*** |  | 17.4 | (0.9) | (0.2) | 16.3 |
| **Fiscal 2024 Plan** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;*NSE/Corp* | 3.5 | (0.5) | (2.7) | (0.1) | 0.2 |
| &nbsp;&nbsp;&nbsp;***Fiscal 2024 Plan*** | 3.5 | (0.5) | (2.7) | (0.1) | 0.2 |
| **Total** | $3.5 | $16.9 | $(3.6) | $(0.3) | $16.5 |

---

(1)Included in Other current liabilities on the Consolidated Balance Sheets as of March 28, 2026 and June 28, 2025.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 14. Income Taxes**

The Company recorded an income tax provision of $7.4 million and $36.1 million for the three and nine months ended March 28, 2026, respectively. The Company recorded an income tax benefit of $16.3 million and an income tax provision of $2.2 million for the three and nine months ended March 29, 2025, respectively.

The income tax provision for the three and nine months ended March 28, 2026 primarily relates to income tax in certain foreign jurisdictions based on the Company's forecasted pre-tax income or loss and revaluation of the Company's German deferred tax assets. The income tax benefit for the three months and the income tax provision for the nine months ended March 29, 2025 primarily relates to the release of valuation allowance related to the acquisition of Inertial labs and income tax in certain foreign and state jurisdictions based on the Company's forecasted pre-tax income or loss.

The income tax provision recorded differs from the expected tax provision that would be calculated by applying the federal statutory rate to the Company's income from continuing operations before taxes primarily due to the changes in valuation allowance for deferred tax assets attributable to the Company's domestic and foreign income from continuing operations and the revaluation of the German deferred tax assets.

As of March 28, 2026 and June 28, 2025, the Company's unrecognized tax benefits (net of Federal benefits) totaled $42.9 million and $42.4 million, respectively, and are included in deferred taxes and other non-current tax liabilities. The Company had $3.5 million accrued for the payment of interest and penalties as of March 28, 2026. The timing and resolution of income tax examinations is uncertain, and the amounts ultimately paid, if any, upon resolution of issues raised by the taxing authorities may differ from the amounts accrued for each year. Although the Company does not expect that our balance of gross unrecognized tax benefits will change materially in the next 12 months, given the uncertainty in the development of ongoing income tax examinations, the Company is unable to estimate the full range of possible adjustments to this balance.

**Note 15. Stockholders' Equity** 

<u>Issuance of Common Stock</u>

During the three months ended March 28, 2026, the Company issued approximately 1.8 million shares of its common stock in connection with the settlement of the remaining 2026 Notes.

During the nine months ended March 28, 2026, the Company issued approximately 9.7 million shares of its common stock related to the settlement of the 2026 Notes, including 7.9 million shares issued in December 2025 and 1.8 million shares issued in March 2026.

<u>Repurchase of Common Stock</u>

In September 2022 the Board of Directors authorized a stock repurchase plan (2022 Repurchase Plan) of up to $300 million effective October 1, 2022, which will remain in effect until the amount authorized has been fully repurchased or until suspension or termination of the program. Under the 2022 Repurchase Plan, the Company is authorized to repurchase shares through a variety of methods, including open market purchases, privately-negotiated transactions or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans. The timing of repurchases under the plan will depend upon business and financial market conditions.

During the nine months ended March 28, 2026, the Company repurchased and subsequently retired 2.7 million shares of its common stock for $30.0 million under the 2022 Repurchase Plan. As of March 28, 2026, the Company had remaining authorization of $168.4 million for future share repurchases under the 2022 Repurchase Plan.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 16. Stock-Based Compensation**

The Company's stock-based compensation includes a combination of time-based restricted stock awards and performance-based awards. Restricted stock awards are granted without an exercise price and are converted to shares immediately upon vesting. When converted into shares upon vesting, shares equivalent in value to the minimum withholding taxes liability on the vested shares are withheld by the Company for the payment of such taxes.

The Company generally estimates the fair value of stock-based awards based on the closing market price of the Company's common stock on the grant date. In the case of performance-based awards that include a market condition, the Company estimates the fair value of the award using a combination of the closing market price of the Company's common stock on the grant date and the Monte Carlo simulation model. For performance-based awards, shares attained over target upon vesting are reflected as awards granted during the period.

Time-based restricted stock awards granted to eligible employees will generally vest in annual installments over a period of three to four years subject to the employees' continuing service to the Company and do not have an expiration date. The Company's performance-based awards may include performance conditions, market conditions, time-based service conditions or a combination thereof and are generally expected to vest in annual installments over a period of three to four years. In addition, the actual number of shares awarded upon vesting of performance-based grants may vary from the target shares depending upon the achievement of the relevant performance or market-based conditions.

During the nine months ended March 28, 2026 and March 29, 2025, the Company granted 3.9 million and 4.5 million time-based restricted stock awards, respectively. The aggregate grant-date fair value of time-based restricted stock awards granted during the nine months ended March 28, 2026 and March 29, 2025 were estimated to be $47.8 million and $39.5 million, respectively.

During the nine months ended March 28, 2026 and March 29, 2025, the Company granted 1.2 million and 1.5 million performance-based awards, respectively. There were less than 0.1 million and no performance-based shares attained over target during the nine months ended March 28, 2026 and March 29, 2025, respectively. The aggregate grant-date fair value of performance-based awards granted during the nine months ended March 28, 2026 and March 29, 2025 were estimated to be $16.3 million and $15.1 million, respectively.

As of March 28, 2026, $77.6 million of unrecognized stock-based compensation costs remain to be amortized.

The impact on the Company's results of operations of recording stock-based compensation by function for the three and nine months ended March 28, 2026 and March 29, 2025, is as follows *(in millions)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Cost of revenues | $1.1 | $2.0 | $3.2 | $4.5 |
| Research and development | 2.5 | 2.3 | 7.3 | 6.7 |
| Selling, general and administrative | 10.3 | 9.8 | 30.7 | 29.3 |
| Total stock-based compensation expense | $13.9 | $14.1 | $41.2 | $40.5 |

---

Approximately $1.2 million and $1.3 million of stock-based compensation was capitalized to inventory as of March 28, 2026 and March 29, 2025, respectively.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 17. Employee Pension and Other Benefit Plans**

The Company sponsors significant qualified and non-qualified pension plans for certain past and present employees in the United Kingdom (U.K.) and Germany. The Company also is responsible for a defined benefit plan comprising of gratuity payments for present employees in India and non-pension post-retirement benefit obligation assumed from a past acquisition.

These pension plans, with the exception of India, have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with an acquisition in fiscal 2010. Benefits are generally based upon years of service and compensation or stated amounts for each year of service.

As of March 28, 2026, the U.K. and India plans were fully funded while the other plans were unfunded. The Company's policy for funded plans is to make contributions equal to or greater than the requirements prescribed by law or regulation. For unfunded plans, the Company pays the post-retirement benefits when due. During the nine months ended March 28, 2026, the Company contributed $1.0 million to the U.K. plan and $4.8 million to the other plans. The funded plan assets consist primarily of managed investments.

The following table presents the components of net periodic cost for the pension and benefits plans (*in millions*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **March 28, 2026** | **March 29, 2025** |
| Interest cost | $0.8 | $0.8 | $2.4 | $2.4 |
| Expected return on plan assets | (0.3) | (0.4) | (1.1) | (1.3) |
| Amortization of net actuarial losses |  |  | 0.1 | 0.2 |
| Net periodic benefit cost | $0.5 | $0.4 | $1.4 | $1.3 |

---

The components of net periodic pension cost, other than the service cost component, are included in Cost of revenues, R&D and SG&A in the Consolidated Statements of Operations.

Both the calculation of the projected benefit obligation and net periodic cost are based upon actuarial valuations. These valuations use participant-specific information such as salary, age, years of service, and assumptions about interest rates, compensation increases and other factors. At a minimum, the Company evaluates these assumptions annually and makes changes as necessary.

Based on actuarial assumptions, the Company expects to incur cash outlays of approximately $7.6 million related to its defined benefit pension plans during fiscal 2026 to make current benefit payments and fund future obligations. As of March 28, 2026, approximately $5.8 million had been incurred. These payments have been estimated based on the same assumptions used to measure the Company's projected benefit obligation at June 28, 2025.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 18. Commitments and Contingencies** 

<u>Legal Proceedings</u>

The Company is subject to a variety of claims and suits that arise from time to time in the ordinary course of its business. While management currently believes that resolving claims against the Company, individually or in aggregate, will not have a material adverse impact on its financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management's view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on the Company's financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

*Tel-Instruments Electronics Corp. Settlement*

In July 2023, the Court of Appeals in the State of Kansas affirmed a lower court decision in a case filed by Aeroflex Wichita (Aeroflex), a VIAVI subsidiary, against Tel-Instrument Electronics Corp. (TIC) and two of its employees with total damages of $7.3 million owed to VIAVI. The lower court case, filed by Aeroflex prior to the acquisition by VIAVI and affirmed by the Kansas Court of Appeals, awarded damages caused by tortious interference and improper use and disclosure of Aeroflex's confidential and proprietary business information used by the defendants to win a competitive U.S. Army contract.

TIC did not file a petition to appeal the decision and acknowledged its obligation to pay damages in full. VIAVI subsequently received total payments of $7.3 million from TIC and the two former employees and recorded a gain to Interest and other income, net in the Consolidated Statements of Operations for the three months ended September 30, 2023.

**Guarantees**

<u>Outstanding Letters of Credit, Performance Bonds and Other Claims</u>

As of March 28, 2026, the Company had standby letters of credit of $10.3 million and performance bonds and other claims of $2.0 million collateralized by restricted cash.

<u>Product Warranties</u>

The following table presents the changes in the Company's warranty reserve during the three and nine months ended March 28, 2026 (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **March 28, 2026** |
| | **Three Months Ended** | **Nine Months Ended** |
| Balance as of beginning of period | $7.0 | $6.7 |
| Provision for warranty | 0.4 | 1.1 |
| Utilization of reserve | (0.6) | (1.6) |
| Adjustments to pre-existing warranties (includes changes in estimates) | (0.1) | (0.1) |
| Acquisition |  | 0.6 |
| Balance as of end of period | $6.7 | $6.7 |

---

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

**Note 19. Operating Segments and Geographic Information** 

The Company evaluates its operating segments in accordance with the authoritative guidance on segment reporting. The Company's Chief Executive Officer as the Company's Chief Operating Decision Maker (CODM) uses operating segment financial information to evaluate segment performance and to allocate resources.

The Company's operating and reportable segments are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Network and Service Enablement (NSE):

NSE provides an integrated portfolio of testing, monitoring, assurance and security solutions to help build, maintain, and optimize telecom and datacom networks. Our solutions address lab and production environments, network management, service assurance and AIOps for any kind of network, including wireless, wireline, cloud, satellite, public safety, military and critical infrastructure. NSE also offers a range of product support and professional services such as repair, calibration, software support and technical assistance for its products.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Optical Security and Performance Products (OSP):

OSP leverages its core optical coating technologies and volume manufacturing capability to design, manufacture, and sell technologies for the anti-counterfeiting, 3D sensing, government and aerospace, automotive and industrial markets.

<u>Segment Reporting</u>

The CODM manages the Company in two broad business categories: NSE and OSP. The CODM evaluates segment performance of the NSE and OSP business based on segment operating margins. The CODM uses segment operating margin to make budgeting and forecasting decisions and to assess the performance of our segments, primarily by monitoring actual results versus the prior year, the annual budget and forecasted results. In addition, the CODM reviews inventory levels and certain other current assets by segment. The Company allocates corporate-level operating expenses to its segment results, except for certain non-core operating and non-operating activities as discussed below.

The Company does not allocate stock-based compensation, acquisition and integrated related charges, amortization of acquisition related intangibles, amortization of acquisition related inventory step-up, legal settlements, restructuring, changes in fair value of contingent consideration liabilities, non-operating income and expenses, or other charges unrelated to core operating performance to its segments because management does not include this information in its measurement of the performance of the operating segments. These items are presented as "Unallocated other expenses" in the table below. Additionally, the Company does not specifically identify and allocate all assets by operating segment.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

The following tables present information on the Company's reportable segments for the three and nine months ended March 28, 2026 and March 29, 2025 (*in millions*):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** | **Three Months Ended March 28, 2026** |
| | **Network and Service Enablement** | **Optical Security and Performance Products** | **Total** |
| Product revenue | $271.7 | $85.3 | $357.0 |
| Service revenue | 49.8 |  | 49.8 |
| Net revenue | $321.5 | $85.3 | $406.8 |
| Cost of revenues | 111.5 | 42.4 |  |
| Research and development | 64.2 | 3.3 |  |
| Selling, general and administrative | 58.8 | 6.1 |  |
| Other segment items<sup>(1)</sup> | 31.6 | 3.4 |  |
| Total operating expense | 154.6 | 12.8 |  |
| Segment operating income | $55.4 | $30.1 | $85.5 |
| Segment operating margin | 17.2% | 35.3% |  |
| Unallocated other expenses |  |  | (60.7) |
| Loss on debt extinguishment |  |  | (3.7) |
| Interest and other income, net |  |  | 7.0 |
| Interest expense |  |  | (14.3) |
| Income before income taxes and equity investment earnings |  |  | $13.8 |

---

(1)Other segment items represents allocation of corporate level operating expenses.

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** | **Three Months Ended March 29, 2025** |
| | **Network and Service Enablement** | **Optical Security and Performance Products** | **Total** |
| Product revenue  | $164.9 | $76.6 | $241.5 |
| Service revenue  | 43.3 |  | 43.3 |
| Net revenue | $208.2 | $76.6 | $284.8 |
| Cost of revenues | 76.9 | 37.1 |  |
| Research and development | 42.6 | 4.1 |  |
| Selling, general and administrative | 42.1 | 6.4 |  |
| Other segment items<sup>(1)</sup> | 24.9 | 3.0 |  |
| Total operating expense | 109.6 | 13.5 |  |
| Segment operating income | $21.7 | $26.0 | $47.7 |
| Segment operating margin | 10.4% | 33.9% |  |
| Unallocated other expenses |  |  | (39.2) |
| Interest and other income, net |  |  | 2.2 |
| Interest expense |  |  | (7.5) |
| Income before income taxes and equity investment earnings |  |  | $3.2 |

---

(1)Other segment items represents allocation of corporate level operating expenses.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** | **Nine Months Ended March 28, 2026** |
| | **Network and Service Enablement** | **Optical Security and Performance Products** | **Total** |
| Product revenue | $685.5 | $246.2 | $931.7 |
| Service revenue | 143.5 |  | 143.5 |
| Net revenue | $829.0 | $246.2 | $1075.2 |
| Cost of revenues | 294.3 | 120.3 |  |
| Research and development | 170.0 | 10.5 |  |
| Selling, general and administrative | 157.9 | 19.3 |  |
| Other segment items<sup>(1)</sup> | 89.7 | 9.2 |  |
| Total operating expense | 417.6 | 39.0 |  |
| Segment operating income | $117.1 | $86.9 | $204.0 |
| Segment operating margin | 14.1% | 35.3% |  |
| Unallocated other expenses |  |  | (160.2) |
| Loss on debt extinguishment |  |  | (46.2) |
| Interest and other income, net |  |  | 12.2 |
| Interest expense |  |  | (37.0) |
| Loss before income taxes and equity investment earnings |  |  | $(27.2) |

---

(1)Other segment items represents allocation of corporate level operating expenses.

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** | **Nine Months Ended March 29, 2025** |
| | **Network and Service Enablement** | **Optical Security and Performance Products** | **Total** |
| Product revenue  | $438.4 | $226.3 | $664.7 |
| Service revenue  | 129.1 |  | 129.1 |
| Net revenue | $567.5 | $226.3 | $793.8 |
| Cost of revenues | 209.6 | 107.3 |  |
| Research and development | 129.7 | 13.0 |  |
| Selling, general and administrative | 121.2 | 18.0 |  |
| Other segment items<sup>(1)</sup> | 75.2 | 7.8 |  |
| Total operating expense | 326.1 | 38.8 |  |
| Segment operating income | $31.8 | $80.2 | $112.0 |
| Segment operating margin | 5.6% | 35.4% |  |
| Unallocated other expenses |  |  | (69.8) |
| Interest and other income, net |  |  | 9.3 |
| Interest expense |  |  | (22.5) |
| Income before income taxes and equity investment earnings |  |  | $29.0 |

---

(1)Other segment items represents allocation of corporate level operating expenses.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

The following table presents information on the assets of the Company's reportable segments at March 28, 2026 and June 28, 2025 (*in millions*):

---

| | | |
|:---|:---|:---|
| | **March 28, 2026** | **June 28, 2025** |
| Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NSE | $107.9 | $74.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OSP | 40.0 | 43.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total inventories, net | 147.9 | 117.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepayments and other current assets - NSE<sup>(1)</sup> | 15.4 | 5.8 |
| Assets not attributed to segments | 2364.5 | 1870.1 |
| Total assets | $2527.8 | $1993.8 |

---

(1)The amount presented represents the prepayments and other current assets attributed to NSE that are reviewed by the CODM. Other NSE related prepayments and current assets are not included as they are not part of the CODM's measure of segment assets.

------

---

| |
|:---|
| <u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u> |
| **VIAVI SOLUTIONS INC.** |
| **NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)** |

---

The Company operates primarily in three geographic regions: Americas, Asia-Pacific, and Europe, Middle East and Africa (EMEA). Net revenue is assigned to the geographic region and country where the Company's product is initially shipped. For example, certain customers may request shipment of the Company's product to a contract manufacturer in one country, which may differ from the location of their end customers.

The following table presents net revenue by the three geographic regions in which the Company operates and net revenue from countries that exceeded 10% of the Company's total net revenue for the three and nine months ended March 28, 2026 and March 29, 2025 *(in millions):*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** | **March 29, 2025** |
| | **Product Revenue** | **Service Revenue** | **Total** | **Product Revenue** | **Service Revenue** | **Total** |
| **Americas:** | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | $134.2 | $19.8 | $154.0 | $75.2 | $14.7 | $89.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Americas | 24.6 | 4.2 | 28.8 | 12.3 | 5.9 | 18.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Americas | $158.8 | $24.0 | $182.8 | $87.5 | $20.6 | $108.1 |
| **Asia-Pacific:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Greater China | $61.6 | $2.6 | $64.2 | $50.8 | $1.1 | $51.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Asia-Pacific | 55.9 | 8.1 | 64.0 | 41.8 | 7.0 | 48.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Asia-Pacific | $117.5 | $10.7 | $128.2 | $92.6 | $8.1 | $100.7 |
| **EMEA:** | $80.7 | $15.1 | $95.8 | $61.4 | $14.6 | $76.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total net revenue** | $357.0 | $49.8 | $406.8 | $241.5 | $43.3 | $284.8 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** | **March 29, 2025** |
| | **Product Revenue** | **Service Revenue** | **Total** | **Product Revenue** | **Service Revenue** | **Total** |
| **Americas:** | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | $351.4 | $53.9 | $405.3 | $217.2 | $44.2 | $261.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Americas | 64.2 | 13.0 | 77.2 | 37.7 | 13.8 | 51.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Americas | $415.6 | $66.9 | $482.5 | $254.9 | $58.0 | $312.9 |
| **Asia-Pacific:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Greater China | $178.0 | $5.9 | $183.9 | $151.1 | $5.0 | $156.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Asia | 123.4 | 21.1 | 144.5 | 102.8 | 21.3 | 124.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Asia-Pacific | $301.4 | $27.0 | $328.4 | $253.9 | $26.3 | $280.2 |
| **EMEA:** | $214.7 | $49.6 | $264.3 | $155.9 | $44.8 | $200.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total net revenue** | $931.7 | $143.5 | $1075.2 | $664.7 | $129.1 | $793.8 |

---

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

**Forward-Looking Statements**

*Statements contained in this Quarterly Report on Form 10-Q, which we also refer to as the Report, which are not historical facts, are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement may contain words such as "anticipate," "believe," "can," "can impact," "could," "continue," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "projects," "should," "will," "will continue to be," "would," or the negative thereof or other comparable terminology regarding beliefs, plans, expectations or intentions regarding the future. Forward-looking statements include statements, but are not limited to statements such as:*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Financial projections and expectations, including profitability of certain business units, synergies, benefits and other matters related to completed and contemplated acquisitions and strategic transactions, plans to reduce costs and improve efficiencies including through restructuring programs, the effects of seasonality on certain business units, the consolidation of the communication industry and continued reliance on key customers for a significant portion of our revenue, future sources of revenue, competition and pricing pressures, the future impact of certain accounting pronouncements, and our estimation of the potential impact and materiality of litigation;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Sufficiency of our sources of funding for working capital, capital expenditures, contractual obligations, acquisitions, stock repurchases, debt repayments and other matters;*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our expectations regarding demand for our products and services, including industry trends and technological advancements that may drive such demand, the role we will play in those advancements and our ability to benefit from such advancements;*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our plans for growth and innovation opportunities;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our plans for continued development, use and protection of our intellectual property;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our strategies for achieving our current business objectives, including related risks and uncertainties;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our plans or expectations relating to investments, execution of capital allocation and debt management strategies, acquisitions, partnerships and other strategic opportunities;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our research and development plans and investments and the expected impact of such plans on our financial performance;*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Our expectations related to our products, including costs associated with the development of new products, product yields, quality and other issues;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Our expectations regarding the impact of tariffs and our strategies for mitigating such impact;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Our expectations related to future tax liabilities resulting from future tax legislation; and*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Our expectations related to macro-economic conditions, including the impact of inflation, fiscal tightening at central banks, changes in foreign exchange rates, the risk of increased tensions and trade actions, including global tariffs, ongoing geopolitical tensions including the conflicts between Russia and Ukraine and in the Middle East, and political instability and economic uncertainty in the Middle East, on our business, operations and financial results.*

*Management cautions that forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause our actual results to differ materially from those projected in such forward-looking statements. These forward-looking statements are only predictions and are subject to risks and uncertainties including those set forth in Part II, Item 1A "Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q and in other documents we file with the U.S. Securities and Exchange Commission. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of these forward-looking statements. Forward-looking statements are made only as of the date of this Report and subsequent facts or circumstances may contradict, obviate, undermine or otherwise fail to support or substantiate such statements. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform such statements to actual results or to changes in our expectations.*

*In addition, Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended June 28, 2025.*

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

*You should read the following discussion of our financial condition and results of operations in conjunction with the financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report on Form 10-Q, particularly in "Risk Factors" and "Forward-Looking Statements."*

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Overview**

VIAVI is a global leader in test and measurement and optical technologies. Our test, monitoring, assurance, and resilient position, navigation and timing solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, we develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets.

To serve our markets we operate the following business segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Network and Service Enablement (NSE); and,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Optical Security and Performance Products (OSP).

During the third quarter of fiscal 2026, the NSE business grew year-over-year as a result of our acquisition of Spirent Communications plc's (Spirent) high-speed ethernet, network security and channel emulation testing business (collectively, the HSE and CE business). Additionally, we continue to see strong demand for lab and production and field products, driven by the data center ecosystem, as well as demand for our aerospace and defense products. OSP performance improved year-over-year driven by anti-counterfeiting and other products (other products include government, industrial and automotive end markets) and 3D Sensing.

Our financial results and long-term growth model will continue to be driven by revenue growth, non-GAAP operating income, non-GAAP operating margin, non-GAAP diluted earnings per share (EPS) and cash flow from operations. We believe these key operating metrics are useful to investors because management uses these metrics to assess the growth of our business and the effectiveness of our marketing and operational strategies.

**Looking Ahead**

As we look forward to the fourth quarter of fiscal 2026, we expect revenue for VIAVI to be up sequentially driven by continued strength in many of our end markets across NSE and OSP. Our long-term focus remains on executing against our strategic priorities to drive revenue and earnings growth, capture market share and continue to optimize our capital structure. We remain positive on our long-term growth drivers and will continue to focus on executing our strategic priorities over the long-term to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Defend and consolidate leadership in core business segments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Invest in secular trends to drive growth and expand total addressable market (TAM);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Extend VIAVI technologies and platforms into lucrative adjacent markets and applications.

In 2025, the U.S. administration imposed additional, broad-based tariffs, under the International Emergency Economic Powers Act (IEEPA), which were then struck down by the U.S. Supreme Court as unconstitutional. In 2026, the administration then imposed temporary replacement tariffs. These, and any other tariffs or other trade actions that may be implemented targeting China or other jurisdictions relevant to VIAVI may increase the cost of certain materials and/or products, thereby adversely affecting our profitability. We continue to take actions to optimize our supply chain, control costs and implement pricing actions to mitigate the evolving impact from tariffs.

**Financial Highlights**

Third quarter fiscal 2026 results included the following notable items:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net revenue of $406.8 million, up $122.0 million or 42.8% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP operating margin of 6.1%, up 310 bps year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP operating margin of 21.0%, up 430 bps year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP net income of $6.4 million, down $13.1 million or 67.2% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP net income of $67.6 million, up $33.7 million or 99.4% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP diluted EPS of $0.03, down $0.06 or 66.7% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP diluted EPS of $0.27, up $0.12 or 80.0% year-over-year.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

A reconciliation of GAAP financial measures to Non-GAAP financial measures is provided below *(in millions, except EPS amounts)*:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** |
| | **Operating Income** | **Operating Margin** | **Operating Income** | **Operating Margin** | **Operating Income** | **Operating Margin** | **Operating Income** | **Operating Margin** |
| GAAP measures | $24.8 | 6.1% | $8.5 | 3.0% | $43.8 | 4.1% | $42.2 | 5.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 13.9 | 3.4% | 14.1 | 4.9% | 41.2 | 3.8% | 40.5 | 5.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent liability | 2.6 | 0.6% | 2.5 | 0.9% | 24.3 | 2.3% | (4.9) | (0.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and integration related charges | 0.7 | 0.2% | 13.3 | 4.7% | 12.4 | 1.1% | 16.7 | 2.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other charges unrelated to core operating performance<sup>(1)</sup> | 4.9 | 1.2% | 0.6 | 0.2% | 11.7 | 1.1% | 0.2 | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquisition related inventory step-up | 0.9 | 0.2% | 1.7 | 0.6% | 6.1 | 0.6% | 1.7 | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 20.4 | 5.0% | 7.3 | 2.5% | 47.6 | 4.4% | 16.0 | 2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and related charges (benefits) | 17.3 | 4.3% | (0.3) | (0.1)% | 16.9 | 1.6% | 0.9 | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Litigation settlement |  | —% |  | —% |  | —% | (1.3) | (0.1)% |
| &nbsp;&nbsp;&nbsp;Total related to Cost of Revenues and Operating Expenses | 60.7 | 14.9% | 39.2 | 13.7% | 160.2 | 14.9% | 69.8 | 8.8% |
| Non-GAAP measures | $85.5 | 21.0% | $47.7 | 16.7% | $204.0 | 19.0% | $112.0 | 14.1% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** |
| | **Net Income** | **Diluted EPS** | **Net Income** | **Diluted EPS** | **Net (Loss) Income** | **Diluted EPS** | **Net Income** | **Diluted EPS** |
| GAAP measures | $6.4 | $0.03 | $19.5 | $0.09 | $(63.1) | $(0.28) | $26.8 | $0.12 |
| Items reconciling GAAP Net Income (Loss) and EPS to Non-GAAP Net Income and EPS: |  |  |  |  |  |  |  |  |
| Stock-based compensation | 13.9 | 0.06 | 14.1 | 0.06 | 41.2 | 0.17 | 40.5 | 0.18 |
| Change in fair value of contingent liability | 2.6 | 0.01 | 2.5 | 0.01 | 24.3 | 0.11 | (4.9) | (0.02) |
| Acquisition and integration related charges | 0.7 |  | 13.3 | 0.06 | 12.4 | 0.05 | 16.7 | 0.08 |
| Other charges unrelated to core operating performance<sup>(1)</sup> | 4.9 | 0.02 | 0.6 |  | 11.7 | 0.05 | 0.2 |  |
| Amortization of acquisition related inventory step-up | 0.9 |  | 1.7 | 0.01 | 6.1 | 0.03 | 1.7 | 0.01 |
| Amortization of intangibles | 20.4 | 0.08 | 7.3 | 0.03 | 47.6 | 0.20 | 16.0 | 0.07 |
| Restructuring and related charges (benefits) | 17.3 | 0.07 | (0.3) |  | 16.9 | 0.07 | 0.9 |  |
| Litigation settlement |  |  |  |  |  |  | (1.3) | (0.01) |
| Non-cash interest expense and other expense<sup>(2)</sup> | 2.4 | 0.01 | 1.3 | 0.01 | 46.6 | 0.20 | 3.5 | 0.02 |
| (Benefit from) provision for income taxes | (1.9) | (0.01) | (26.1) | (0.12) | 8.5 | 0.04 | (24.4) | (0.11) |
| &nbsp;&nbsp;Total related to Net Income and EPS | 61.2 | 0.24 | 14.4 | 0.06 | 215.3 | 0.92 | 48.9 | 0.22 |
| Non-GAAP measures | $67.6 | $0.27 | $33.9 | $0.15 | $152.2 | $0.64 | $75.7 | $0.34 |
| Shares used in per share calculation for Non-GAAP EPS |  | 249.5 |  | 226.9 |  | 236.9 |  | 225.2 |

---

(1)Included in the three months ended March 28, 2026 are charges of $3.9 million related to the write off of property, plant and equipment, $0.3 million of accelerated depreciation and other charges unrelated to core operating performance. In addition, included in the nine months ended March 28, 2026 are $3.5 million of losses on disposal of long-lived assets, $2.1 million charge for restoration services for a VIAVI facility impacted by a fire and other charges unrelated to core operating performance. Included in the nine months ended March 29, 2025 is a gain of $0.9 million on the sale of assets previously classified as held for sale and other charges unrelated to core operating performance.

(2)The Company incurred losses of $3.7 million and $46.2 million for the three and nine months ended March 28, 2026, respectively, in connection with the extinguishment of certain 1.625% Senior Convertible Notes and prepayments of the Term Loan B.

&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Use of Non-GAAP (Adjusted) Financial Measures**

The Company provides non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP EPS financial measures as supplemental information regarding the Company's operational performance and believes providing this additional information allows investors to see Company results through the eyes of management, to evaluate more clearly and consistently the Company's core operational performance and expenses and evaluate the efficacy of the methodology used by management to measure such performance. The Company uses the measures disclosed in this Report to evaluate the Company's historical and prospective financial performance, as well as its performance relative to its competitors. Specifically, management uses these items to further its own understanding of the Company's core operating performance, which the Company believes represents its performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from core operating performance items such as those relating to certain purchase price accounting adjustments, amortization of acquisition related intangibles, amortization expense related to acquisition related inventory step-up, stock-based compensation, legal settlements, restructuring, changes in fair value of contingent consideration liabilities, certain investing and acquisition related expenses and other activities and income tax expenses or benefits that management believes are not reflective of such ordinary, ongoing and core operating activities. The non-GAAP adjustments are outlined below.

*Cost of revenues, costs of research and development and costs of selling, general and administrative*: The Company's GAAP presentation of gross margin and operating expenses may include (i) additional depreciation and amortization from changes in estimated useful life and the write-down of certain property, plant and equipment and intangibles, (ii) charges such as severance, benefits and outplacement costs related to restructuring plans with a specific and defined term, (iii) costs for facilities not required for ongoing operations, and costs related to the relocation of certain equipment from these facilities and/or contract manufacturer facilities, (iv) stock-based compensation, (v) amortization expense related to acquired intangibles, (vi) amortization expense related to acquisition related inventory step-up, (vii) changes in fair value of contingent consideration liabilities, (viii) acquisition related transaction and integration costs related to acquired entities, (ix) significant legal settlements and other contingencies and (x) other charges unrelated to our core operating performance comprised mainly of other costs and contingencies unrelated to current and future operations, including transformational initiatives such as the implementation of simplified automated processes, site consolidations and reorganizations. The Company excludes these items in calculating non-GAAP operating margin, non-GAAP net income and non-GAAP EPS.

*Non-cash interest expense and other expense*: The Company excludes certain expenses, including loss on debt extinguishment, accretion of debt discount, and other non-cash activities that management believes are not reflective of such ordinary, ongoing and core operating activities, when calculating non-GAAP net income and non-GAAP EPS.

*Income tax expense or benefit*: The Company excludes certain non-cash tax expense or benefit items, such as (i) the utilization of net operating losses (NOLs) where valuation allowances were released, (ii) intra-period tax allocation benefit and (iii) the tax effect for amortization of non-tax deductible intangible assets, in calculating non-GAAP net income and non-GAAP EPS.

Non-GAAP financial measures are not in accordance with, preferable to, or an alternative for, generally accepted accounting principles in the United States. The GAAP measure most directly comparable to non-GAAP operating income is operating income. The GAAP measure most directly comparable to non-GAAP operating margin is operating margin. The GAAP measure most directly comparable to non-GAAP net income is net income. The GAAP measure most directly comparable to non-GAAP EPS is earnings per share.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**RESULTS OF OPERATIONS**

The results of operations for the current period are not necessarily indicative of results to be expected for future periods. The following table summarizes selected Consolidated Statements of Operations items (*in millions*):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **Change** | **Percent Change** | **March 28, 2026** | **March 29, 2025** | **Change** | **Percent Change** |
| Segment net revenue: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;NSE | $321.5 | $208.2 | $113.3 | 54.4% | $829.0 | $567.5 | $261.5 | 46.1% |
| &nbsp;&nbsp;&nbsp;OSP | 85.3 | 76.6 | 8.7 | 11.4% | 246.2 | 226.3 | 19.9 | 8.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net revenue | $406.8 | $284.8 | $122.0 | 42.8% | $1075.2 | $793.8 | $281.4 | 35.4% |
| Amortization of acquired technologies | $13.0 | $6.1 | $6.9 | 113.1% | $32.4 | $12.7 | $19.7 | 155.1% |
| Percentage of net revenue | 3.2% | 2.1% |  |  | 3.0% | 1.6% |  |  |
| Gross profit | $234.1 | $160.7 | $73.4 | 45.7% | $613.7 | $457.6 | $156.1 | 34.1% |
| Gross margin | 57.5% | 56.4% |  |  | 57.1% | 57.6% |  |  |
| Research and development | $71.0 | $50.0 | $21.0 | 42.0% | $192.9 | $151.5 | $41.4 | 27.3% |
| Percentage of net revenue | 17.5% | 17.6% |  |  | 17.9% | 19.1% |  |  |
| Selling, general and administrative | $113.6 | $101.3 | $12.3 | 12.1% | $344.9 | $259.7 | $85.2 | 32.8% |
| Percentage of net revenue | 27.9% | 35.6% |  |  | 32.1% | 32.7% |  |  |
| Amortization of other intangibles | $7.4 | $1.2 | $6.2 | 516.7% | $15.2 | $3.3 | $11.9 | 360.6% |
| Percentage of net revenue | 1.8% | 0.4% |  |  | 1.4% | 0.4% |  |  |
| Restructuring and related charges (benefits) | $17.3 | $(0.3) | $17.6 | (5866.7)% | $16.9 | $0.9 | $16.0 | 1777.8% |
| Percentage of net revenue | 4.3% | 0.1% |  |  | 1.6% | 0.1% |  |  |
| Loss on debt extinguishment | $(3.7) | $— | $(3.7) | NM | $(46.2) | $— | $(46.2) | NM |
| Percentage of net revenue | 0.9% | —% |  |  | 4.3% | —% |  |  |
| Interest and other income, net | $7.0 | $2.2 | $4.8 | 218.2% | $12.2 | $9.3 | $2.9 | 31.2% |
| Percentage of net revenue | 1.7% | 0.8% |  |  | 1.1% | 1.2% |  |  |
| Interest expense | $(14.3) | $(7.5) | $(6.8) | 90.7% | $(37.0) | $(22.5) | $(14.5) | 64.4% |
| Percentage of net revenue | 3.5% | 2.6% |  |  | 3.4% | 2.8% |  |  |
| Provision for (benefit from) income taxes | $7.4 | $(16.3) | $23.7 | (145.4)% | $36.1 | $2.2 | $33.9 | 1540.9% |
| Percentage of net revenue | 1.8% | 5.7% |  |  | 3.4% | 0.3% |  |  |
| Equity investment earnings | $— | $— | $— | —% | $0.2 | $— | $0.2 | NM |
| Percentage of net revenue | —% | —% |  |  | —% | —% |  |  |

---

NM - Percentage change not considered meaningful

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Net Revenue** 

Revenue from our service offerings exceeds 10% of our total consolidated net revenue and is presented separately in our Consolidated Statements of Operations. Service revenue primarily consists of maintenance and support, extended warranty, professional services and post-contract support in addition to other services such as calibration and repair services. When evaluating the performance of our segments, management focuses on total net revenue, gross profit and segment operating income and not the product or service categories. Consequently, the following discussion of business segment performance focuses on total net revenue, gross profit and segment operating income consistent with our approach for managing the business.

<u>Three and Nine Months Ended March 28, 2026 and March 29, 2025</u>

Net revenue increased by $122.0 million, or 42.8%, during the three months ended March 28, 2026 compared to the same period a year ago. Our acquisition of Spirent's HSE and CE business contributed $54.3 million during the three months ended March 28, 2026. Inertial Labs contributed $22.6 million during the three months ended March 28, 2026 compared to $7.7 million in the same period a year ago. Additionally, we continue to see demand of lab and production and field products driven by the data center ecosystem. OSP performance improved year-over-year driven by anti-counterfeiting and other products and 3D Sensing.

Net revenue increased by $281.4 million, or 35.4%, during the nine months ended March 28, 2026 compared to the same period a year ago. Our acquisition of Spirent's HSE and CE business contributed $97.3 million during the nine months ended March 28, 2026. Inertial Labs contributed $62.4 million during the nine months ended March 28, 2026 compared to $7.7 million in the same period a year ago. Additionally, we continue to see demand of lab and production and field products driven by the data center ecosystem. OSP performance improved year-over-year driven by anti-counterfeiting and other products and 3D Sensing.

Product revenues increased by $115.5 million, or 47.8%, during the three months ended March 28, 2026 compared to the same period a year ago, driven by volume increases in NSE and OSP. Product revenues from Spirent's HSE and CE business contributed $41.6 million during the three months ended March 28, 2026. Product revenues from Inertial Labs contributed $22.6 million during the three months ended March 28, 2026 compared to $7.7 million in the same period a year ago.

Product revenues increased by $267.0 million, or 40.2%, during the nine months ended March 28, 2026 compared to the same period a year ago, driven by volume increases in NSE and OSP. Product revenues from Spirent's HSE and CE business contributed $74.5 million during the nine months ended March 28, 2026. Product revenues from Inertial Labs contributed $62.4 million during the nine months ended March 28, 2026 compared to $7.7 million in the same period a year ago.

Service revenues increased by $6.5 million, or 15.0%, during the three months ended March 28, 2026 compared to the same period a year ago, driven by the acquisition of Spirent's HSE and CE business which contributed $12.7 million offset by a decline primarily in Wireless during the three months ended March 28, 2026.

Service revenues increased by $14.4 million, or 11.2%, during the nine months ended March 28, 2026 compared to the same period a year ago, driven by the acquisition of Spirent's HSE and CE business which contributed $22.8 million offset by a decline primarily in Wireless during the nine months ended March 28, 2026.

Going forward, we expect to continue to encounter a number of industry and market risks and uncertainties. For example, uncertainty around the timing of our customers' procurement decisions on infrastructure maintenance and upgrades and decisions on new infrastructure investments or uncertainty about speed of adoption of 5G technology at a commercially viable scale. This may limit our visibility, and consequently, our ability to predict future revenue, seasonality, profitability and general financial performance, which could create period-over-period variability in our financial measures and present foreign exchange rate risks. Global tariffs could increase our costs and impact our business.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

We cannot predict when or to what extent these uncertainties will be resolved. Our revenues, profitability and general financial performance may also be affected by: (a) pricing pressures due to, among other things, a highly concentrated customer base, increasing competition, particularly from Asia-based competitors and a general commoditization trend for certain products; (b) strategic execution challenges arising from competition with larger and more well-resourced competitors; (c) product mix variability in our markets, which affects revenue and gross margin; (d) fluctuations in customer buying patterns, which cause demand, revenue and profitability volatility; (e) the current trend of communication industry consolidation, which is expected to continue, that directly affects our NSE customer base and adds additional risk and uncertainty to our financial and business projections; (f) the impact of ongoing global trade policies, tariffs and sanctions; and (g) regulatory or economic developments and/or technology challenges that slow or change the rate of adoption of 5G, 3D sensing and other emerging secular technologies and platforms.

**Revenue by Region**

We operate in three geographic regions, including the Americas, Asia-Pacific and Europe Middle East and Africa (EMEA). Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which may differ from the location of their end customers.

The following table presents net revenue by the three geographic regions we operate in and net revenue from countries that exceeded 10% of our total net revenue (*in millions*):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** | **March 28, 2026** | **March 28, 2026** | **March 29, 2025** | **March 29, 2025** |
| **Americas:** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States | $154.0 | 37.8% | $89.9 | 31.6% | $405.3 | 37.7% | $261.4 | 32.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Americas | 28.8 | 7.1% | 18.2 | 6.4% | 77.2 | 7.2% | 51.5 | 6.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Americas | $182.8 | 44.9% | $108.1 | 38.0% | $482.5 | 44.9% | $312.9 | 39.4% |
| **Asia-Pacific:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Greater China | $64.2 | 15.8% | $51.9 | 18.3% | $183.9 | 17.1% | $156.1 | 19.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Asia-Pacific | 64.0 | 15.7% | 48.8 | 17.1% | 144.5 | 13.4% | 124.1 | 15.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Asia-Pacific | $128.2 | 31.5% | $100.7 | 35.4% | $328.4 | 30.5% | $280.2 | 35.3% |
| **EMEA:** | $95.8 | 23.6% | $76.0 | 26.6% | $264.3 | 24.6% | $200.7 | 25.3% |
| **Total net revenue** | $406.8 | 100.0% | $284.8 | 100.0% | $1075.2 | 100.0% | $793.8 | 100.0% |

---

Net revenue from customers outside the Americas represented 55.1% of net revenue during the three and nine months ended March 28, 2026. Net revenue from customers outside the Americas represented 62.0% and 60.6% of net revenue, respectively, during the three and nine months ended March 29, 2025.

We expect revenue from customers outside of the United States to continue to be an important part of our overall net revenue and an increasing focus for net revenue growth opportunities.

**Amortization of Acquired Technologies (Cost of revenues)**

Amortization of acquired technologies within Cost of revenues increased $6.9 million or 113.1% and $19.7 million or 155.1% during the three and nine months ended March 28, 2026 compared to the same period a year ago. This increase is primarily due to the amortization of intangibles acquired through Spirent's HSE and CE business and Inertial Labs.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Gross Margin**

Gross margin increased by 1.1 percentage points during the three months ended March 28, 2026 from 56.4% in the same period a year ago to 57.5% in the current period. The increase was primarily driven by the higher volume and favorable product mix in NSE partially offset by unfavorable product mix in OSP and an increase in amortization of intangibles.

Gross margin decreased by 0.5 percentage points during the nine months ended March 28, 2026 from 57.6% in the same period a year ago to 57.1% in the current period. The decrease was primarily driven by the increase in amortization of intangibles and amortization of acquisition related inventory step-up, partially offset by higher volume and favorable product mix.

As discussed in more detail under "Net Revenue" above, we sell products in certain markets that are consolidating, undergoing product, architectural and business model transitions, have high customer concentrations, are highly competitive (increasingly due to Asia-Pacific-based competition), are price sensitive and/or are affected by customer seasonal and mix variant buying patterns. We expect these factors to continue to result in variability of our gross margin.

**Research and Development**

Research and Development (R&D) expense increased by $21.0 million, or 42.0%, during the three months ended March 28, 2026 compared to the same period a year ago. This increase was primarily due to incremental cost from the acquisitions of Spirent's HSE and CE business and Inertial Labs. As a percentage of net revenue, R&D expense decreased by 0.1 percentage points during the three months ended March 28, 2026 compared to the same period a year ago.

R&D expense increased by $41.4 million, or 27.3%, during the nine months ended March 28, 2026 compared to the same period a year ago. This increase was primarily due to incremental cost from the acquisitions of Spirent's HSE and CE business and Inertial Labs. As a percentage of net revenue, R&D expense decreased by 1.2 percentage points during the nine months ended March 28, 2026 compared to the same period a year ago.

We believe that continuing our investments in R&D is critical to attaining our strategic objectives. We plan to continue to invest in R&D and new products that will further differentiate us in the marketplace.

**Selling, General and Administrative**

Selling, General and Administrative (SG&A) expense increased by $12.3 million, or 12.1%, during the three months ended March 28, 2026 compared to the same period a year ago. This increase was primarily due to the incremental cost from the acquisitions of Spirent's HSE and CE business and Inertial Labs partially offset by lower acquisition and integration related charges. As a percentage of net revenue, SG&A expense decreased 7.7 percentage points during the three months ended March 28, 2026 compared to the same period a year ago.

SG&A expense increased by $85.2 million, or 32.8%, during the nine months ended March 28, 2026 compared to the same period a year ago. This increase was primarily due the incremental cost from the acquisitions of Spirent's HSE and CE business and Inertial Labs and the change in fair value of acquisition related contingent consideration. As a percentage of net revenue, SG&A expense decreased 0.6 percentage points during the nine months ended March 28, 2026 compared to the same period a year ago.

**Amortization of Intangibles (Operating expenses)**

Amortization of intangibles within Operating expenses increased $6.2 million or 516.7% and $11.9 million or 360.6% during the three and nine months ended March 28, 2026 compared to the same period a year ago. This increase is primarily due to the amortization of intangibles acquired through Spirent's HSE and CE business and Inertial Labs, partially offset by certain intangibles becoming fully amortized.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Restructuring** 

The Company's restructuring events are primarily intended to reduce costs, consolidate operations, integrate various acquisitions, streamline product manufacturing and address market conditions.

During the third quarter of fiscal 2026, management approved a restructuring and workforce reduction plan (the Fiscal 2026 Plan) across our NSE and OSP segments and Corporate functions intended to improve operational efficiencies, better align the Company's workforce with current business needs and strategic growth opportunities and includes integration of recently acquired businesses. The Fiscal 2026 Plan includes a global workforce reduction, facilities rationalization and asset write-offs. The Company expects approximately 5% of its global workforce to be affected. We estimate annualized gross cost savings of approximately $30.0 million upon completion of the Fiscal 2026 plan, excluding any one-time charges as a result of the restructuring activities. The Company anticipates the Fiscal 2026 Plan to be substantially complete by the end of calendar year 2026.

During the fourth quarter of fiscal 2024, management approved a restructuring and workforce reduction plan (the Fiscal 2024 Plan) across various functions intended to improve operational efficiencies and better align the Company's workforce with current business needs. The Company expects approximately 7% of its global workforce to be affected, impacting both segments and corporate functions. We estimate annualized gross cost savings of approximately $25.0 million excluding any one-time charges as a result of the restructuring activities initiated under the Fiscal 2024 Plan. The Company anticipates the Fiscal 2024 Plan will be complete by the end of fiscal 2026.

The restructuring and workforce reduction plan initiated in the second quarter of fiscal 2023 (the Fiscal 2023 Plan) across various functions to better align the Company's workforce with current business needs and strategic growth opportunities was completed in the first quarter of fiscal 2025. The Fiscal 2023 Plan affected approximately 5% of the Company's workforce and resulted in an estimated annualized gross cost savings of approximately $25.0 million excluding any one-time charges.

As of March 28, 2026, our total restructuring accrual was $16.5 million.

During the three and nine months ended March 28, 2026, the Company recorded restructuring charges of $17.4 million of employee severance, benefits and outplacement costs related to the Fiscal 2026 Plan. During the three and nine months ended March 28, 2026, the Company recorded restructuring benefits of $0.1 million and $0.5 million, respectively, related to the Fiscal 2024 Plan. During the three and nine months ended March 29, 2025, the Company recorded restructuring benefits of $0.3 million and charges of $1.1 million, respectively, related to the Fiscal 2024 Plan. During the nine months ended March 29, 2025, the Company recorded a restructuring benefit of $0.2 million related to the Fiscal 2023 Plan.

We estimate future cash payments of $16.3 million and $0.2 million under the Fiscal 2026 Plan and Fiscal 2024 Plan, respectively, funded by operating cash flow.

Refer to "Note 13. Restructuring and Related Charges" for more information.

**Loss on Debt Extinguishment**

During the three months ended March 28, 2026, the Company made prepayments of $150.0 million under the Term Loan Credit Agreement. The prepayments were accounted for as partial extinguishments, with the carrying amount of the portion of debt prepaid, including the proportionate unamortized debt issuance costs, derecognized. The difference between the reacquisition price and the carrying amount of $3.7 million was recorded as Loss on debt extinguishment in the Consolidated Statements of Operations.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

During the nine months ended March 28, 2026, Company made prepayments of $150.0 million under the Term Loan Credit Agreement. The prepayments were accounted for as partial extinguishments, with the carrying amount of the portion of debt prepaid, including the proportionate unamortized debt issuance costs, derecognized. The Company also entered into separate privately-negotiated agreements with certain holders of its 1.625% Senior Convertible Notes due 2026 (2026 Notes). The Company issued 7.9 million shares of its common stock for $103.5 million principal amount of the 2026 Notes in December 2025. The Company issued $100.9 million aggregate principal amount of its 0.625% Senior Convertible Notes due 2031 (2031 Notes) to certain holders of the 2026 Notes in exchange for $97.5 million principal amount of the 2026 Notes in August 2025. These 2026 Notes exchange transactions were accounted for as extinguishments which resulted in the write-off of unamortized debt discount and issuance costs of $1.6 million on the extinguished notes. Accrued interest of $0.7 million on the 2026 Notes was included in the exchange for the 2031 Notes. The total loss from these extinguishments was $46.2 million recorded as Loss on debt extinguishment in the Consolidated Statements of Operations.

Refer to "Note 11. Debt" for more information.

**Interest and other income, net**

Interest and other income, net, was $7.0 million during the three months ended March 28, 2026 compared to $2.2 million during the same period a year ago. This $4.8 million change was primarily driven by an increase in other income related to an adjustment to a financing obligation, an increase in interest income due to higher cash balance and favorable foreign exchange impact as the balance sheet hedging program provided more favorable offset to the remeasurement of underlying foreign exchange exposures during the current period.

Interest and other income, net, was $12.2 million during the nine months ended March 28, 2026 compared to $9.3 million during the same period a year ago. This $2.9 million change was primarily driven by an increase in other income related to an adjustment to a financing obligation, an increase in interest income due to higher cash balance offset by an unfavorable foreign exchange impact as the balance sheet hedging program provided a less favorable offset to the remeasurement of underlying foreign exchange exposures during the current period.

**Interest Expense**

Interest expense increased by $6.8 million, or 90.7%, during the three months ended March 28, 2026 compared to the same period a year ago. This increase was primarily a result of higher outstanding debt with higher average interest rates as a result of the issuance of Term Loan B and additional amortization of debt issuance costs in the current period partially offset by a decrease in the accretion of debt discount on the 2026 Notes as a result of the debt extinguishments as well as settlement at maturity during the current period.

Interest expense increased by $14.5 million, or 64.4%, during the nine months ended March 28, 2026 compared to the same period a year ago. This increase was primarily a result of higher outstanding debt with higher average interest rates as a result of the issuance of Term Loan B and additional amortization of debt issuance costs in the current period partially offset by a decrease in the accretion of debt discount on the 2026 Notes as a result of the debt extinguishments as well as settlement at maturity during the current period.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Provision for Income Taxes**

We recorded an income tax provision of $7.4 million and $36.1 million for the three and nine months ended March 28, 2026, respectively. We recorded an income tax benefit of $16.3 million and an income tax provision of $2.2 million for the three and nine months ended March 29, 2025, respectively.

The income tax provision for the three and nine months ended March 28, 2026, primarily relates to income tax in certain foreign jurisdictions based on our forecasted pre-tax income and the revaluation of German deferred tax assets. The income tax benefit for the three months and the income tax provision for the nine months ended March 29, 2025, primarily relates to the release of valuation allowance related to our acquisition of Inertial labs and income tax in certain foreign and state jurisdictions based on our forecasted pre-tax income or loss.

The income tax provision recorded differs from the expected tax provision that would be calculated by applying the federal statutory rate to our income from continuing operations before taxes primarily due to changes in the valuation allowance for deferred tax assets attributable to our domestic and foreign income from continuing operations and revaluation of the German deferred tax assets.

As of March 28, 2026 and June 28, 2025, our unrecognized tax benefits (net of Federal benefits) totaled $42.9 million and $42.4 million, respectively, and are included in deferred taxes and other non-current tax liabilities. We had $3.5 million accrued for the payment of interest and penalties as of March 28, 2026. The timing and resolution of income tax examinations are uncertain, and the amounts ultimately paid, if any, upon resolution of issues raised by the taxing authorities may differ from the amounts accrued for each year. Although we do not expect that our balance of gross unrecognized tax benefits will change materially in the next 12 months, given the uncertainty in the development of ongoing income tax examinations, we are unable to estimate the full range of possible adjustments to this balance.

**Operating Segment Information**

Information related to our operating segments was as follows *(in millions)*:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **March 28, 2026** | **March 29, 2025** | **Change** | **Percentage Change** | **March 28, 2026** | **March 29, 2025** | **Change** | **Percentage Change** |
| **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** | **Network and Service Enablement** |
| &nbsp;&nbsp;&nbsp;Net revenue | $321.5 | $208.2 | $113.3 | 54.4% | $829.0 | $567.5 | $261.5 | 46.1% |
| &nbsp;&nbsp;&nbsp;Gross profit | 210.0 | 131.3 | 78.7 | 59.9% | 534.7 | 357.9 | 176.8 | 49.4% |
| &nbsp;&nbsp;&nbsp;Gross margin | 65.3% | 63.1% |  |  | 64.5% | 63.1% |  |  |
| &nbsp;&nbsp;&nbsp;Operating income | $55.4 | $21.7 | $33.7 | 155.3% | $117.1 | $31.8 | $85.3 | 268.2% |
| &nbsp;&nbsp;&nbsp;Operating margin | 17.2% | 10.4% |  |  | 14.1% | 5.6% |  |  |
| **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** | **Optical Security and Performance Products** |
| &nbsp;&nbsp;&nbsp;Net revenue | $85.3 | $76.6 | $8.7 | 11.4% | $246.2 | $226.3 | $19.9 | 8.8% |
| &nbsp;&nbsp;&nbsp;Gross profit | 42.9 | 39.5 | 3.4 | 8.6% | 125.9 | 119.0 | 6.9 | 5.8% |
| &nbsp;&nbsp;&nbsp;Gross margin | 50.3% | 51.6% |  |  | 51.1% | 52.6% |  |  |
| &nbsp;&nbsp;&nbsp;Operating income | $30.1 | $26.0 | $4.1 | 15.8% | $86.9 | $80.2 | $6.7 | 8.4% |
| &nbsp;&nbsp;&nbsp;Operating margin | 35.3% | 33.9% |  |  | 35.3% | 35.4% |  |  |

---

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

<u>Network and Service Enablement</u>

NSE net revenue increased by $113.3 million, or 54.4%, during the three months ended March 28, 2026 compared to the same period a year ago, primarily driven by higher volume in Lab and Production ($52.5 million contributed by our acquisition of Spirent's HSE business), Aerospace and Defense ($22.6 million contributed by Inertial Labs during the three months ended March 28, 2026 compared to $7.7 million in the same period a year ago) and Fiber and Access Solutions, partially offset by lower volume in Wireless.

NSE net revenue increased by $261.5 million, or 46.1%, during the nine months ended March 28, 2026 compared to the same period a year ago, primarily driven by higher volume in Lab and Production ($93.8 million contributed by our acquisition of Spirent's HSE business), Aerospace and Defense ($62.4 million contributed by Inertial Labs during the nine months ended March 28, 2026 compared to $7.7 million in the same period a year ago) and Fiber and Access Solutions, partially offset by lower volume in Wireless.

NSE gross margin increased by 2.2 percentage points during the three months ended March 28, 2026 to 65.3% from 63.1% in the same period a year ago primarily due to higher volume and favorable product mix.

NSE gross margin increased by 1.4 percentage points during the nine months ended March 28, 2026 to 64.5% from 63.1% in the same period a year ago primarily due to higher volume and favorable product mix.

NSE operating margin increased by 6.8 percentage points during the three months ended March 28, 2026 to 17.2% from 10.4% in the same period a year ago primarily due to higher volume resulting in operating leverage.

NSE operating margin increased by 8.5 percentage points during the nine months ended March 28, 2026 to 14.1% from 5.6% in the same period a year ago primarily due to higher volume resulting in operating leverage.

<u>Optical Security and Performance Products</u>

OSP net revenue increased by $8.7 million, or 11.4%, during the three months ended March 28, 2026 compared to the same period a year ago, primarily driven by Anti-Counterfeiting and Other revenues.

OSP net revenue increased by $19.9 million, or 8.8%, during the nine months ended March 28, 2026 compared to the same period a year ago, primarily driven by Anti-Counterfeiting and Other revenues.

OSP gross margin decreased by 1.3 percentage points during the three months ended March 28, 2026 to 50.3% from 51.6% in the same period a year ago primarily due to unfavorable product mix.

OSP gross margin decreased by 1.5 percentage points during the nine months ended March 28, 2026 to 51.1% from 52.6% in the same period a year ago primarily due to unfavorable product mix.

OSP operating margin increased by 1.4 percentage points during the three months ended March 28, 2026 to 35.3% from 33.9% in the same period a year ago primarily due to higher volume.

OSP operating margin decreased by 0.1 percentage points during the nine months ended March 28, 2026 to 35.3% from 35.4% in the same period a year ago primarily due to the aforementioned decrease in gross margin.

**Liquidity and Capital Resources**

We believe our existing liquidity and sources of liquidity, namely operating cash flows, credit facility capacity, and access to capital markets, will continue to be adequate to meet our liquidity needs, including but not limited to, contractual obligations, working capital and capital expenditure requirements, contingent consideration obligations, financing strategic initiatives, funding debt maturities, and executing purchases under our share repurchase program over the next twelve months and beyond. However, there are a number of factors that could positively or negatively impact our liquidity position, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Global economic conditions which affect demand for our products and services and impact the financial stability of our suppliers and customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in accounts receivable, inventory or other operating assets and liabilities which affect our working capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increase in capital expenditure to support the revenue growth opportunity of our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in customer payment terms and patterns, which typically results in customers delaying payments or negotiating favorable payment terms to manage their own liquidity positions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Timing of payments to our suppliers;

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Factoring or sale of accounts receivable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Volatility in fixed income and credit markets which impact the liquidity and valuation of our investment portfolios;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Volatility in credit markets that impact our ability to obtain additional financing on favorable terms or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Volatility in foreign exchange markets which impacts our financial results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Possible investments or acquisitions of complementary businesses, products or technologies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Principal payment obligations of our 3.75% Senior Notes due 2029 and 0.625% Senior Convertible Notes due 2031 (together the "Notes"), Term Loan B maturing in 2032 and covenants that restrict our debt level and credit facility capacity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issuance or repurchase of debt which may include open market purchases of the Notes prior to their maturity and prepayment of Term Loan B;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issuance or repurchase of our common stock or other equity securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Challenges in repatriating funds from certain foreign jurisdictions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Factors beyond our control that may impact timing of and/or appropriation of government funding for certain of our strategic research and development programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potential funding of pension liabilities either voluntarily or as required by law or regulation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Compliance with covenants and other terms and conditions related to our financing arrangements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The risks and uncertainties detailed in Item 1A "Risk Factors" section of our Quarterly Report on Form 10-Q.

<u>Cash and Cash Equivalents and Short-Term Investments</u>

Our cash and cash equivalents and short-term investments mainly consist of investments in institutional money market funds and short-term deposits at major global financial institutions. Our strategy is focused on capital preservation and supporting our liquidity requirements that meet high credit quality standards, as specified in our investment policy approved by the Audit Committee of our Board of Directors. Our investments in debt securities and marketable equity securities are primarily classified as available for sale or trading assets and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses on available-for-sale investments are recorded as Other comprehensive income (loss) and reported as a separate component of stockholders' equity. As of March 28, 2026, U.S. subsidiaries owned approximately 34.1% of our cash and cash equivalents, short-term investments and restricted cash.

As of March 28, 2026, the majority of our cash investments have maturities of 90 days or less and are of high credit quality. Nonetheless we could realize investment losses under adverse market conditions. During the three months ended March 28, 2026, we have not realized material investment losses but we can provide no assurance that the value or liquidity of our investments will not be impacted by adverse conditions in the financial markets. In addition, we maintain cash balances in operating accounts with third-party financial institutions. These balances in the U.S. may exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits. While we monitor the cash balances in our operating accounts and adjust as appropriate, these cash balances could be impacted if the underlying financial institutions fail.

<u>Senior Secured Asset-Based Revolving Credit Facility</u>

On December 30, 2021, we entered into a credit agreement (the Credit Agreement) with Wells Fargo Bank, National Association (Wells Fargo), as administrative agent, and other lender-related parties. The Credit Agreement provides for a senior secured asset-based revolving credit facility. On October 16, 2025, we amended the Credit Agreement to reduce the commitment from a maximum aggregate amount of $300.0 million to $200.0 million to be in line with borrowing base availability and extend the maturity from December 30, 2026 to October 16, 2030. The Credit Agreement also provides that, under certain circumstances, we may increase the aggregate amount of revolving commitments thereunder by an aggregate amount of up to $100.0 million so long as certain conditions are met.

As of March 28, 2026, we had no borrowings under this facility and our available borrowing capacity was approximately $182.7 million, net of outstanding standby letters of credit of $3.8 million.

Refer to "Note 11. Debt" for more information.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

<u>Convertible Notes</u>

On August 20, 2025, the Company issued $100.9 million aggregate principal amount of the 2031 Notes in exchange for $97.5 million principal amount of the 2026 Notes and issued and sold $149.1 million aggregate principal amount of the 2031 Notes. Concurrent with this transaction, the Company repurchased and subsequently retired 2.7 million shares of its common stock for $30.0 million under the 2022 Repurchase Plan.

On December 22, 2025, the Company settled $103.5 million principal amount of the 2026 Notes in exchange for 7.9 million shares of its common stock.

On March 15, 2026, the outstanding $49.0 million principal amount of the 2026 Notes matured. Nearly all holders of the 2026 Notes chose to convert and the settlement of the conversion resulted in a cash payment of $49.4 million, including $49.0 million in principal and $0.4 million in accrued interest, and the issuance of 1.8 million shares of its common stock for conversion value above par.

During the third quarter of fiscal 2026, the closing price of the Company's common stock exceeded 130% of the applicable conversion price of the 2031 Notes, on at least 20 of the last 30 consecutive trading days of the calendar quarter, causing the 2031 Notes to be convertible by their holders for the period April 1, 2026 to June 30, 2026. As a result, the $244.5 million carrying value of the 2031 Notes has been reclassified to short-term debt.

Refer to "Note 11. Debt" for more information.

<u>Term Loan B</u>

On October 16, 2025, the Company entered into a Term Loan Credit Agreement with Wells Fargo, as administrative agent, and certain lender-related parties. The Term Loan Credit Agreement provided for a senior secured term loan of $600.0 million maturing on October 16, 2032. The proceeds from the term loans under the Term Loan Credit Agreement were used to finance a portion of the acquisition of Spirent's HSE and CE business, acquisition related expenses and will be used for general corporate purposes. On January 5, 2026, and March 4, 2026, the Company made prepayments of $100.0 million and $50.0 million, respectively, under the Term Loan Credit Agreement. The prepayments were accounted for as partial extinguishments, with the carrying amount of the portion of debt prepaid, including the proportionate unamortized debt issuance costs, derecognized. The total loss from the prepayments was $3.7 million recorded as Loss on debt extinguishment in the Consolidated Statements of Operations.

Refer to "Note 11. Debt" for more information.

<u>Contingent Consideration</u>

As of March 28, 2026, the fair value of the contingent consideration liability for Inertial Labs was $68.2 million with $43.0 million and $25.2 million included in Other current liabilities and Other non-current liabilities, respectively, on the Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

<u>Cash Flows for the Nine Months Ended March 28, 2026</u>

As of March 28, 2026, our combined balance of cash and cash equivalents and restricted cash increased by $79.2 million to $511.3 million from $432.1 million as of June 28, 2025.

During the nine months ended March 28, 2026, Cash provided by operating activities was $47.2 million, consisting of net loss of $63.1 million adjusted for non-cash charges (e.g., depreciation, amortization, stock-based compensation and other non-cash items) totaling $233.7 million, including changes in deferred tax balances, and changes in operating assets and liabilities that used $123.4 million. Changes in our operating assets and liabilities related to an increase in accounts receivable of $62.5 million due to billings outpacing collections, an increase in inventory of $37.3 million related to demand changes, a decrease in accrued expenses and other current and non-current liabilities of $30.6 million, a decrease in deferred revenue of $13.2 million, excluding the impact of deferred revenue from the acquisition of Spirent's HSE and CE business, due to timing of support billings and project acceptances and an increase in other current and non-current assets of $5.7 million. These were partially offset by an increase in accounts payable of $13.4 million, an increase in accrued payroll and related expenses of $9.1 million due primarily to variable pay and timing of payroll and an increase in income taxes payable of $3.4 million.

During the nine months ended March 28, 2026, Cash used in investing activities was $417.3 million, primarily resulting from $399.3 million used for the acquisition of Spirent's HSE and CE business, $20.0 million used for capital expenditures and $0.7 million used for the acquisition of Inertial Labs partially offset by $2.6 million in proceeds from the sale of assets.

During the nine months ended March 28, 2026, Cash provided by financing activities was $449.2 million, primarily resulting from $600 million in proceeds from the issuance of a Term Loan B, $149.1 million in proceeds from the issuance of the 2031 Notes and $6.5 million in proceeds from the issuance of common stock under our employee stock purchase plan. These were partially offset by $199.0 million payments of debt, $30.0 million cash paid to repurchase common stock under our share repurchase program, $29.8 million contingent consideration payment, $23.4 million of debt issuance costs paid, $23.0 million in withholding tax payments on the vesting of restricted stock and performance-based awards and $1.2 million in other financing activities.

<u>Share Repurchase Program</u>

During the nine months ended March 28, 2026, we repurchased and subsequently retired 2.7 million shares of our common stock for $30.0 million pursuant to our 2022 Repurchase Plan. As of March 28, 2026, the Company had remaining authorization of $168.4 million for future share repurchases under the 2022 Repurchase Plan.

Refer to "Note 15. Stockholders Equity" for more information.

**Contractual Obligations**

There were no material changes to our existing contractual commitments during the third quarter of fiscal 2026.

**Off-Balance Sheet Arrangements**

We do not have any off-balance sheet arrangements, as such term is defined in rules promulgated by the SEC, that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors, other than the guarantees discussed in "Note 18. Commitments and Contingencies."

**Employee Equity Incentive Plan**

Our stock-based benefit plans are a broad-based, long-term retention program that is intended to attract and retain employees and align stockholder and employee interests. Refer to "Note 16. Stock-Based Compensation" for more details.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Employee Defined Benefit Plans and Other Post-retirement Benefits**

We sponsor significant qualified and non-qualified pension plans for certain past and present employees in the U.K. and Germany. The Company also is responsible for a defined benefit plan comprising of gratuity payments for present employees in India. These pension plans, with the exception of India, have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with an acquisition in fiscal 2010.

The U.K. and India plans were fully funded while the German plans, which were initially established as "pay-as-you-go" plans, are unfunded. As of March 28, 2026, our pension plans were under-funded by $48.3 million since the post-retirement benefit obligation (PBO) exceeded the fair value of plan assets. Pension plan assets are managed by external third parties and we monitor the performance of our investment managers. As of March 28, 2026, the fair value of plan assets had decreased approximately 3.1% since June 28, 2025, our most recent fiscal year end.

We are also responsible for the non-pension PBO assumed from a past acquisition of $0.3 million.

In estimating the expected return on plan assets, we consider historical returns on plan assets, adjusted for forward-looking considerations, inflation assumptions and the impact of active management of the plan's invested assets. While it is not possible to accurately predict future rate movements, we believe our current assumptions are appropriate. Refer to "Note 17. Employee Pension and Other Benefit Plans" for more details.

**Recently Issued Accounting Pronouncements**

Refer to "Note 2. Recently Issued Accounting Pronouncements" regarding the effect of certain recent accounting pronouncements on our Consolidated Financial Statements.

**Critical Accounting Estimates**

Our Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP), which require management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities, net revenue and expenses, and the disclosure of contingent assets and liabilities. Our estimates are based on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. We believe that the accounting estimates employed and the resulting balances are reasonable; however, actual results may differ from these estimates and such differences may be material.

<u>Contingent Purchase Consideration</u>

For contingent purchase consideration, the fair value of such earn-out liabilities are generally determined using a Monte Carlo Simulation that includes significant unobservable inputs such as the projected revenues of the acquired business over the earn-out period. The fair value of contingent consideration liabilities is remeasured at each reporting period at the estimated fair value based on the inputs on the date of remeasurement. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and given the inherent uncertainties in making these estimates, actual results are likely to differ from the amounts originally recorded and could be materially different.

<u>Post-retirement benefit obligation (PBO)</u>

A key actuarial assumption in calculating the net periodic cost and the PBO is the discount rate. Changes in the discount rate impact the interest cost component of the net periodic benefit cost calculation and PBO due to the fact that the PBO is calculated on a net present value basis. Decreases in the discount rate will generally increase pre-tax cost, recognized expense and the PBO. Increases in the discount rate tend to have the opposite effect. We estimate a 50-basis point decrease or increase in the discount rate would cause a corresponding increase or decrease, respectively, in the PBO of approximately $4.0 million based upon data as of June 28, 2025.

**Item 3. Quantitative and Qualitative Disclosure About Market Risks**

The Company's market risk has not changed materially from the foreign exchange and interest rate risks disclosed in Item 7A of the Company's Annual Report on Form 10-K for the fiscal year ended June 28, 2025.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Item 4. Controls and Procedures** 

**Evaluation of Disclosure Controls and Procedures**

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), which are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), as appropriate, to allow timely decisions regarding required disclosure. Our management, with the participation of our CEO and CFO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of March 28, 2026.

**Changes in Internal Control Over Financial Reporting**

There have been no changes in the Company's internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

**Limitations on Effectiveness of Controls**

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures of our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control systems will be achieved. No evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company, have been detected. Accordingly, our disclosure controls and procedures provide reasonable assurance of achieving their objective.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**PART II—OTHER INFORMATION**

**[Item 1. Legal Proceedings](#i9d5e57b28a2a4895b07b82f12543ee34_268)**

We are subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against us, individually or in aggregate, will not have a material adverse impact on our financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management's view of these matters may change in the future. If an unfavorable final outcome were to occur, it may have a material adverse impact on our financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**ITEM 1A. RISK FACTORS**

**<u>Global Risks</u>**

***Geopolitical conditions, including political turmoil and volatility, regional conflicts, terrorism and war could result in market instability, which could negatively impact our business results.***

We operate globally and sell our products in countries throughout the world. Escalations in regional conflicts, including the ongoing conflicts between Russia and Ukraine and in the Middle East, ongoing and expanding economic sanctions, political instability and economic uncertainty in the Middle East, and the risk of increased tensions between the U.S. and China, could curtail or prohibit our ability to transfer certain technologies, to sell our products and solutions, or to continue to operate in certain locations. Foreign companies with a presence in China are facing increasing operational challenges and enhanced scrutiny from governmental entities in the region. Further, it is possible that the U.S.-Chinese geopolitical tensions could result in government measures that could adversely impact our business. The U.S. administration has implemented and could implement further broad-based global tariffs that could adversely impact trade relations and result in higher costs. Tariff rates continue to evolve and therefore the impact, including those of any potential retaliatory tariffs, is difficult to forecast. International conflict has contributed to (i) increased pressure on the supply chain and increased energy and fuel costs, which could increase the cost of manufacturing, selling and delivering products and solutions (ii) inflation, which could result in increases in the cost of manufacturing products, reduced customer purchasing power, increased price pressure, and reduced or cancelled orders (iii) increases in cybersecurity attacks and (iv) general market instability, all of which could adversely impact our financial results.

**<u>Risks Related to Our Business Strategy and Industry</u>**

***Our future profitability is not assured.***

Our profitability in a particular period will be impacted by revenue, product mix and operational costs that vary significantly across our product portfolio and business segments.

Specific factors that may undermine our profit and financial objectives include, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Uncertainty around the timing of our customers procurement decisions on infrastructure maintenance and upgrades;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Uncertain future telecom carrier and cable operator capital and R&D spending levels, which particularly affects our NSE segment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse changes to our product mix, both fundamentally (resulting from new product transitions, the declining profitability of certain legacy products and the termination of certain products with declining margins, among other things) and due to quarterly demand fluctuations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pricing pressure across our NSE product lines due to competitive forces, particularly from Asia-based competitors, advanced chip component shortages, and a highly concentrated customer base for many of our product lines, which may offset some of the cost improvements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Strategic execution challenges arising from competition with larger and more well-resourced competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our OSP segment operating margin may experience some downward pressure as a result of a higher mix of 3D sensing products and increased operating expenses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Longer lead times for components and resources for our products, for example, recent memory chip shortages which leads to higher component prices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Resource rationing, including rationing of utilities like electricity by governments and/or service providers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Budgetary constraints that impact or slow customer inventory consumption;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increasing commoditization of previously differentiated products, and the attendant negative effect on average selling prices and profit margins;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Execution challenges, which limit revenue opportunities and harm profitability, market opportunities and customer relations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Decreased revenue associated with terminated or divested product lines;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Redundant costs related to periodic transitioning of manufacturing and other functions to lower-cost locations;

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Ongoing costs associated with organizational transitions, consolidations and restructurings, which are expected to continue in the nearer term;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cyclical demand for our currency products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changing market and economic conditions, including impacts due to tariffs, economic sanctions and export restrictions, the ongoing conflicts between Russia and Ukraine and in the Middle East, ongoing and expanding economic sanctions, political instability and economic uncertainty in the Middle East, tensions and trade sanctions between the U.S. and China, supply chain constraints, pricing and inflationary pressures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A limited number of customers may account for a substantial portion of our revenue in any given period and our operating results may be adversely affected by the timing, size, and concentration of large customer orders, including orders from government entities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of any prolonged government shutdown on our business, particularly in the aerospace and defense sectors, along with any governmental actions impacting the defense sector;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Ability of our customers, partners, manufacturers and suppliers to purchase, market, sell, manufacture and/or supply our products and services, including as a result of disruptions arising from supply chain constraints;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial stability of our customers, including the solvency of private sector customers and statutory authority for government customers to purchase goods and services; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Factors beyond our control resulting from pandemics and similar outbreaks, manufacturing restrictions, travel restrictions and shelter-in-place orders to control the spread of a disease regionally and globally, and limitations on the ability of our employees and our suppliers' and customers' employees to work and travel.

Taken together, these factors limit our ability to predict future profitability levels and to achieve our long-term profitability objectives. If we fail to achieve profitability expectations, the price of our debt and equity securities, as well as our business and financial condition, may be materially adversely impacted.

***Rapid technological change in our industry presents us with significant risks and challenges, and if we are unable to keep up with the rapid changes, our customers may purchase less of our products.***

Our success depends upon our ability to deliver both our current product offerings and new products and technologies on time and at an acceptable cost to our customers. The markets for our products are characterized by rapid technological change, frequent new product introductions, substantial capital investment, changes in customer requirements and a constantly evolving industry. Our future performance will depend on the successful development, introduction and market acceptance of new and enhanced products that address these issues and provide solutions that meet our customers' current and future needs. As a technology company, we also constantly encounter quality, volume and cost concerns such as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our continuing cost reduction programs, which include site and organization consolidations, asset divestitures, outsourcing the manufacture of certain products to contract manufacturers, other outsourcing initiatives and reductions in employee headcount, requirements related to re-establishment and re-qualification by our customers of complex manufacturing lines, and modifications to systems, planning and operational infrastructure. During this process, we have experienced, and may continue to experience, additional costs, delays in re-establishing volume production levels, planning difficulties, inventory issues, factory absorption concerns and systems integration problems.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Variability of manufacturing yields caused by difficulties in the manufacturing process, the effects from a shift in product mix, changes in product specifications and the introduction of new product lines. These difficulties can reduce yields or disrupt production and thereby increase our manufacturing costs and adversely affect our margin.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potentially significant costs to correct defective products (despite rigorous testing for quality both by our customers and by us), which could include lost future sales of the affected product and other products, and potentially severe customer relations problems, litigation and damage to our reputation.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our dependence on a limited number of vendors, who are often small and specialized, for raw materials, packages and standard components. We also rely on contract manufacturers around the world to manufacture certain products. Our business could continue to be adversely affected by this dependency. Specific concerns we periodically encounter with our suppliers include stoppages or delays of supply, insufficient vendor resources to supply our requirements, substitution of more expensive or less reliable parts, receipt of defective parts or contaminated materials, increases in the price of supplies and an inability to obtain reduced pricing from our suppliers in response to competitive pressures. Additionally, the ability of our contract manufacturers to fulfill their obligations may be affected by economic, political or other forces that are beyond our control. Any such failure could have a material impact on our ability to meet customers' expectations and may materially impact our operating results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• New product programs and introductions, which involve changing product specifications and customer requirements, unanticipated engineering complexities, difficulties in reallocating resources and overcoming resource limitations and increased complexity, exposing us to yield and product risk internally and with our suppliers.

These factors could cause strain on our execution capabilities and customer relations. We expect the impact of these issues will become more pronounced as we continue to introduce new product offerings and when overall demand increases. We have seen and could continue to see periodic difficulty responding to customer delivery expectations for some of our products, and yield and quality problems, particularly with some of our new products and higher volume products which could require additional funds and other resources to respond to these execution challenges. From time to time, we have had to divert resources from new product R&D and other functions to assist with resolving these matters. If we do not improve our performance in these areas, our operating results may be harmed, the commercial viability of new products may be challenged, and our customers may choose to reduce or terminate their purchases of our products and purchase additional products from our competitors.

***Unfavorable, uncertain or unexpected conditions in the transition to new technologies may cause our growth forecasts to be inaccurate and/or cause fluctuations in our financial results.***

Growth forecasts are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. Our estimates of the market opportunities related to network infrastructure, 3D sensing and other developing technologies, including AI, are subject to significant uncertainty and are based on assumptions and estimates, including our internal analysis, industry experience and third-party data. Accordingly, these markets may not develop in the manner or in the time periods we anticipate, and our estimated market opportunities may prove to be materially inaccurate.

If domestic and global economic conditions worsen, including as a result of pricing and inflationary pressures, overall spending on infrastructure, 3D sensing and other developing technologies may be reduced, which would adversely impact demand for our products in these markets. In addition, unfavorable developments with evolving laws and regulations worldwide related to such technologies may limit or slow the rate of global adoption, impede our strategy, and negatively impact our long-term expectations in these markets.

Our growth and ability to serve a significant portion of these markets are subject to many factors including our success in implementing our business strategy as well as market adoption and expansion of network infrastructure, 3D sensing and other applications for consumer electronics. We may not be able to serve a significant portion of these markets and our growth forecasts should not be taken as indicative of our future growth. Even if the markets and rates of adoption develop in the manner or in the time periods we anticipate, if we do not have timely, competitively priced, market-accepted products available to meet our customers' planned roll-out of infrastructure platforms and systems, 3D sensing products and other technologies, we may miss a significant opportunity and our business, financial condition, results of operations and cash flows could be materially and adversely affected.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***We may experience increased pressure on our pricing and contract terms due to our reliance on a limited number of customers for a significant portion of our sales.***

We believe that we will continue to rely upon a limited number of customers for a significant portion of our revenues for the foreseeable future. Any failure by us to continue capturing a significant share of key customer sales could materially harm our business. Dependence on a limited number of customers exposes us to the risk that order reductions from any one customer can have a material adverse effect on periodic revenue. Due to the current trend of communication industry consolidation, we may have increased dependence on fewer customers who may be able to exert increased pressure on our prices and other contract terms. Customer consolidation activity and periodic manufacturing and inventory initiatives could also create the potential for disruptions in demand for our products as a consequence of such customers streamlining, reducing or delaying purchasing decisions.

We have a strategic alliance with SICPA to market and sell our OVP and OVMP product lines for banknote anti-counterfeiting applications worldwide. A material reduction in sales, or loss of the relationship with SICPA, may harm our business and operating results as we may be unable to find a substitute marketing and sales partner or develop these capabilities ourselves in a timely manner.

***Movement towards virtualized networks and software solutions may result in lower demand for our hardware products and increased competition.***

The market for our NSE segment is increasingly looking towards virtualized networks and software solutions. This trend may result in lower demand for our legacy hardware products. Additionally, barriers to entry are generally lower for software solutions, which may lead to increased competition for our products, solutions and services.

***We face a number of risks related to our strategic transactions.***

Our strategy continues to include periodic acquisitions and divestitures of businesses and technologies. Strategic transactions of this nature involve numerous risks, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Competition for suitable acquisition targets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inability to consummate deals on favorable or acceptable terms, or due to failure to obtain stockholder, government, regulatory or other necessary approvals or satisfy other closing conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Diversion of management's attention from normal daily operations of the business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potential difficulties in completing projects associated with in-process R&D;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Difficulties in entering markets in which we have no or limited prior experience and where competitors have stronger market positions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Difficulties in obtaining or providing sufficient transition services and accurately projecting the time and cost associated with providing these services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inability of an acquisition to further our business strategy as expected or overpay for, or otherwise not realize the expected return on our investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Expected earn-outs may not be achieved in the time frame or at the level expected or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lack of ability to recognize or capitalize on expected growth, synergies or cost savings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Insufficient net revenue to offset increased expenses associated with acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potential loss of key employees of the acquired companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Difficulty in forecasting revenues and margins;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse public health developments, epidemic disease or pandemics in the countries in which we operate or our customers are located, including regional quarantines restricting the movement of people or goods, reductions in labor supply or staffing, the closure of facilities to protect employees, including those of our customers, disruptions to global supply chains and both our and our suppliers' ability to deliver materials and products on a timely or cost-effective basis, shipment, acceptance or verification delays, the resulting overall significant volatility and disruption of financial markets, and economic instability affecting customer spending patterns; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inadequate internal control procedures and disclosure controls to comply with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or poor integration of a target company's or business's procedures and controls.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

Acquisitions may also cause us to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issue common stock that would dilute our current stockholders' percentage ownership and may decrease earnings per share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assume liabilities, some of which may be unknown at the time of the acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Record goodwill and non-amortizable intangible assets that will be subject to impairment testing and potential periodic impairment charges;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incur additional debt to finance such acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incur amortization expenses related to certain intangible assets; and/or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Acquire, assume, or become subject to litigation related to the acquired businesses or assets.

***VIAVI is subject to risks associated with its acquisitions, and any failure to realize anticipated benefits of such acquisitions.***

VIAVI may not be able to realize the benefits of any completed or contemplated acquisitions and strategic transactions, including synergies, value creation or other benefits of such acquisitions, fully or at all, or on the timeline VIAVI expects. At times, the resources of VIAVI and the acquired businesses or the attention of certain members of their management may be focused on completion and integration of the acquisition and diverted from day-to-day business operations, which may disrupt ongoing business. In addition, the process of integrating, and any failure to successfully integrate, the acquired businesses may have an adverse impact on the Company, including from risks related to significant transaction and integration costs, unknown liabilities, employee turnover, divergence of management attention, litigation and/or regulatory actions related to the acquisition or if the acquired business does not perform as expected, which may cause an adverse financial impact on the Company.

***We may not generate positive returns on our research and development strategy.***

Developing our products is expensive, and the investment in product development may involve a long payback cycle. We expect to continue to invest heavily in R&D in order to expand the capabilities of 3D sensing and smart phone sensors, handheld spectrometer solution and portable test instruments, introduce new products and features and build upon our technology. We expect that our results of operations may be impacted by the timing and size of these investments. In addition, these investments may take several years to generate positive returns, if ever.

**<u>Operational Risks</u>**

***Our restructuring activities could adversely affect our business and results of operations.***

We have from time-to-time engaged in restructuring activities to realign our cost base with current and anticipated future market conditions, including the restructuring programs initiated during fiscal 2024 and fiscal 2026. Significant risks associated with these types of actions that may impair our ability to achieve the anticipated cost reductions or disrupt our business include delays in the implementation of anticipated workforce reductions in highly regulated locations outside of the U.S. and the failure to meet operational targets due to the loss of key employees. In addition, our ability to achieve the anticipated cost savings and other benefits from these actions within the expected timeframe is subject to many estimates and assumptions. These estimates and assumptions are subject to significant economic, competitive and other uncertainties, some of which are beyond our control. If these estimates and assumptions are incorrect, if we experience delays, or if other unforeseen events occur, our business and results of operations could be adversely affected.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***Management transitions and talent retention create uncertainties that could harm our business.***

Management changes could adversely impact our results of operations and our customer relationships and may make recruiting for future management positions more difficult. Our executives and other key personnel are generally at-will employees, we generally do not have employment or non-compete agreements with our other employees, and we cannot assure you that we will be able to retain them. We have in the past experienced, and could continue to experience changes in our leadership team. Competition for people with the specific technical and other skills we require is significant. We could be impacted by new restrictions imposed by the U.S. government on, or curtailing of H1-B and other work visas and permits. We and our impacted and prospective employees may face greater evidentiary burden to prove eligibility for immigration benefits. Further, employees in certain categories may not be able to renew work authorizations or benefit from automatic extensions of work permits. We may face difficulties in attracting, retaining and motivating employees. If we are unable to attract and retain qualified executives and employees, or to successfully integrate any newly hired personnel within our organization, we may be unable to achieve our operating objectives, which could negatively impact our financial performance and results of operations.

***We face risks related to our international operations and revenue.***

Our customers are located throughout the world. In addition, we have significant operations outside North America, including product development, manufacturing, sales and customer support operations.

Our international presence exposes us to certain risks, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fluctuations in exchange rates between the U.S. dollar and among the currencies of the countries in which we do business may adversely affect our operating results by negatively impacting our revenues or increasing our expenses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to comply with the laws and regulations of the countries in which we do business, including, among others, customs, import/export, product compliance, economic sanctions, anti-bribery, anti-competition, climate/sustainability regulations, and tax and data privacy laws, which may be subject to sudden and unexpected changes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Difficulties in establishing and enforcing our intellectual property rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Tariffs and other trade restrictions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Political, legal and economic instability in foreign markets, particularly in those markets in which we maintain manufacturing and product development facilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Strained or worsening relations between the U.S., Russia, China and the Middle East and related impacts on other countries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Difficulties in staffing and management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Language and cultural barriers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Seasonal reductions in business activities in the countries where our international customers are located;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Integration of foreign operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Longer payment cycles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Difficulties in management of foreign distributors; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potential adverse tax consequences.

International conflicts and global and regional health pandemics have affected and may in the future affect the manufacturing and shipment of goods globally. Any delay in production or delivery of our products due to an extended closure of our suppliers' plants could adversely impact our business, along with delays in shipment of our products as well as increased logistics costs.

We expect that net revenue from customers outside North America will continue to account for a significant portion of our total net revenue. Lower sales levels that typically occur during the summer months in Europe and some other overseas markets may materially and adversely affect our business. In addition, the revenues we derive from many of our customers depend on international sales and further expose us to the risks associated with such international sales.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**<u>Information Security, Technology and Intellectual Property Risks</u>**

***Our business and operations could be adversely impacted in the event of a failure of information technology infrastructure.***

We rely upon the capacity, reliability and security of our information technology infrastructure and our ability to expand and continually update this infrastructure in response to our changing needs. In some cases, we rely upon third-party hosting and support services to meet these needs. We and our third-party providers have experienced increasingly sophisticated cybersecurity attacks, which can take the form of phishing emails, malware, malicious websites, ransomware, exploitation of application vulnerabilities, and nation-state attacks. These kinds of attacks or threats of attacks can lead to increased operational impairment; intellectual property theft; fraud; extortion; harm to employees or customers; violation of privacy or security laws and other litigation and legal risks; and reputational risks. The growing and evolving cyber-risk environment means that individuals, companies, and organizations of all sizes, including ourselves, our customers, suppliers and our hosting and support partners, are increasingly vulnerable to attacks and disruptions on their networks and systems by a wide range of actors on an ongoing and regular basis. We also design and manage IT systems and products that contain IT systems for various customers, and generally face the same threats for these systems as for our own internal systems.

Our network security controls are comprised of administrative, physical and technical controls, which include, but are not limited to, the implementation of firewalls, anti-virus protection, patches, log monitors, routine backups, off-site storage, network audits and other routine updates and modifications. We also routinely monitor and develop our internal information technology systems to address risks to our information systems. However, there can be no assurance that the controls we implement and internal information technology systems we develop will be adequate and successful. Our systems are regularly targeted by bad actors and, in some cases, have been affected by computer viruses, natural disasters, unauthorized access and other similar disruptions and attacks that continue to emerge and evolve. Any system failure, accident or security breach could result in disruptions to our business processes, network degradation, and system downtime, along with the potential that a third-party will gain unauthorized access to, or acquire intellectual property, proprietary business information, and data related to our employees, customers, suppliers, and business partners, including personal data. While we maintain system data and security logs, our logging also may not be sufficient to fully investigate a security incident. To the extent that any disruption, degradation, downtime or other security event results in a loss or damage to our data or systems, or in inappropriate disclosure of confidential or personal information, it could adversely impact us and our clients, potentially resulting in, among other things, financial losses, loss of customers or business, our inability to transact business on behalf of our clients, adverse impact on our brand and reputation, violations of applicable privacy and other laws, regulatory fines, penalties, litigation, reimbursement or other compensation costs, and/or additional compliance costs. We may also incur additional costs related to cybersecurity risk management and remediation. We or our service providers, if applicable, may suffer losses relating to cyber-attacks or other information security breaches in the future and any insurance coverage may not be adequate to cover all the costs resulting from such events. Our efforts to reduce the risk of such attacks or to detect attacks that occur may not be successful.

***If we have insufficient proprietary rights or if we fail to protect those we have, our business would be materially harmed.*** 

We seek to protect our products and our product roadmaps in part by developing and/or securing proprietary rights relating to those products, including patents, trade secrets, know-how and continuing technological innovation. The steps taken by us to protect our intellectual property may not adequately prevent misappropriation or ensure that others will not develop competitive technologies or products and the costs associated with protecting our intellectual property may outweigh the benefits. Other companies may be investigating or developing other technologies that are similar to our own. It is possible that patents may not be issued from any of our pending applications or those we may file in the future and, if patents are issued, the claims allowed may not be sufficiently broad to deter or prohibit others from making, using or selling products that are similar to ours. We do not own patents in every country in which we sell or distribute our products, and thus others may be able to offer identical products in countries where we do not have intellectual property protection. In addition, the laws of some territories in which our products are or may be developed, manufactured or sold, including Europe, Asia-Pacific or Latin America, may not protect our products and intellectual property rights to the same extent as the laws of the U.S.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

Any patents issued to us may be challenged, invalidated or circumvented. Additionally, we are currently a licensee in all of our operating segments for a number of third-party technologies, software and intellectual property rights from academic institutions, our competitors and others, and are required to pay royalties to these licensors for the use thereof. Unless we are able to obtain such licenses on commercially reasonable terms, patents or other intellectual property held by others could inhibit our development of new products, impede the sale of some of our current products, substantially increase the cost to provide these products to our customers, and could have a significant adverse impact on our operating results. In the past, licenses generally have been available to us where third-party technology was necessary or useful for the development or production of our products. However, in the future licenses to third-party technology may not be available on commercially reasonable terms, if at all.

***Our products may be subject to claims that they infringe the intellectual property rights of others.***

Lawsuits and allegations of patent infringement and violation of other intellectual property rights occur in our industry on a regular basis. We have received in the past, and anticipate that we will receive in the future, notices from third parties claiming that our products infringe their proprietary rights. Over the past several years there has been a marked increase in the number and potential severity of third-party patent infringement claims, primarily from two distinct sources. First, large technology companies, including some of our customers and competitors, are seeking to monetize their patent portfolios and have developed large internal organizations that have approached us with demands to enter into license agreements. Second, patent-holding companies, entities that do not make or sell products (often referred to as "patent trolls"), have claimed that our products infringe upon their proprietary rights. We will continue to respond to these claims in the course of our business operations. In the past, the resolution of these disputes has not had a material adverse impact on our business or financial condition; however, this may not be the case in the future. Further, the litigation or settlement of these matters, regardless of the merit of the claims, could result in significant expense to us and divert the efforts of our technical and management personnel, whether or not we are successful. If we are unsuccessful, we could be required to expend significant resources to develop non-infringing technology or to obtain licenses to the technology that is the subject of the litigation. We may not be successful in such development, or such licenses may not be available on terms acceptable to us, if at all. Without such a license, we could be enjoined from future sales of the infringing product or products, which could adversely affect our revenues and operating results.

***The use of open-source software and generative artificial intelligence may expose us to risks and harm our intellectual property position.***

Certain of the software and/or firmware that we use and distribute (as well as that of our suppliers, manufacturers and customers) may be, derived from, or contain, "open-source" software, which is software that is generally made available to the public by its authors and/or other third parties, as well as generative artificial intelligence (GenAI) technology (discussed further below). Such open-source software is often made available under licenses which impose obligations in the event the software or derivative works thereof are distributed or re-distributed. These obligations may require us to make source code for the derivative works available to the public, and/or license such derivative works under a particular type of license, rather than the forms of license customarily used to protect our own software products. In the event that a court rules that these licenses are unenforceable, or in the event the copyright holder of any open-source software were to successfully establish in court that we had not complied with the terms of a license for a particular work, we could be required to release the source code of that work to the public and/or stop distribution of that work. Additionally, open-source licenses are subject to occasional revision. In the event future iterations of open-source software are made available under a revised license, such license revisions may adversely affect our ability to use such future iterations.

Similarly, GenAI technology and, more recently, Agentic AI have proliferated including as a feature in existing commercially available products, some of which we use. GenAI is a type of machine-learning model capable of generating various types of content, including data, text and images. Agentic AI refers to autonomous or semi-autonomous AI systems that can reason, plan, and take actions to achieve complex, multi-step goals with minimal human supervision. Use of these tools could expose us to data and network security risks. These risks include the exposure of our intellectual property, confidential and proprietary information (including customer information) to unknown recipients; the introduction of malware into our network; and the creation of content subject to copyright, trademark, or other intellectual property protection of an unknown third party.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**<u>Legal, Regulatory and Compliance Risks</u>**

***Certain of our products are subject to governmental and industry regulations, certifications and approvals.***

The commercialization of certain of the products we design, manufacture and distribute may be more costly due to required government approval and industry acceptance processes. For example, in our OSP segment, development of applications for our anti-counterfeiting and special effects pigments may require significant testing that could delay our sales. In addition, durability testing by the automobile industry of our special effects pigments used with automotive paints can take up to three years. If we change a product for any reason, including technological changes or changes in the manufacturing process, prior approvals or certifications may be invalid and we may need to go through the approval process again. If we are unable to obtain these or other government or industry certifications in a timely manner, or at all, our operating results could be adversely affected.

***We receive formal and informal government inquiries or audits related to our products, practices or services from time to time.***

We receive formal and informal inquiries from, or become subject to, investigations by various government authorities regarding our business and compliance with federal, state and local laws, regulations, or standards. Any determination or allegation that our operations, products, activities, or the activities of our employees, contractors or agents, are not in compliance with existing laws, regulations or standards, could adversely affect our business. Even if such inquiries or investigations do not result in the imposition of fines, interruptions to our business, loss of suppliers or other third-party relationships, terminations of necessary licenses and permits, the existence of those inquiries or investigations alone could create negative publicity that could cause business or reputational harm.

***U.S. government trade actions and restrictions could have an adverse impact on our business, financial position, and results of operation.***

Trade tensions between the U.S. and China have continued to escalate, with the U.S. and China both imposing a variety of trade barriers against the other, including various export control restrictions and tariffs.

Huawei Technologies Co. Ltd. and a score of non-U.S. affiliates (collectively, Huawei) are on the Entity List of the Bureau of Industry and Security of the U.S. Department of Commerce (BIS), which imposes limitations on the supply of most U.S. items and product support to Huawei. U.S. export controls also restrict all persons from sharing many items produced domestically and abroad from U.S. technology and software with Huawei. Certain VIAVI products are subject to the restrictions; however, the ongoing impact is not expected to be material to our overall operations.

Moreover, the additional tariffs imposed by the U.S. administration in 2025 (and, following the U.S. Supreme Court striking down such tariffs as unconstitutional, the temporary replacement tariffs imposed in 2026), and any other tariffs or other trade actions that may be implemented targeting China or other jurisdictions relevant to VIAVI, may increase the cost of certain materials and/or products, thereby adversely affecting our profitability. These actions could require us to pass these costs to our customers, which could decrease demand for our products, and could adversely impact our business.

Furthermore, the geopolitical and economic uncertainty and/or instability that may result from changes in the relationship among the United States, Taiwan and China, may, directly or indirectly, materially harm our business, financial condition and results of operations. For example, certain of our suppliers are dependent on products sourced from Taiwan, which are prevalent in certain global markets, most specifically semiconductor manufacturing. Hence, greater restrictions and/or disruptions of our suppliers' ability to operate facilities and/or do business in these jurisdictions may increase the cost of certain materials and/or limit the supply of products and may result in deterioration of our profit margins, a potential need to increase our pricing and, in so doing, may decrease demand for our products and thereby adversely impact our revenue or profitability.

Due to the ongoing conflict between Russia and Ukraine, the U.S., European Union (E.U.), and United Kingdom (U.K.) have broadened restrictions on supply to Russia of various items, including shipments of many technology, telecommunications and consumer electronics products. We suspended transactions in the region effective February 2022 which negatively impacted our business in the region. The ongoing situation in Ukraine as well as the potential for additional trade actions or retaliatory cyber-attacks aimed at infrastructure or supply chains, could have an impact on our future operations and financial results.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***Failure to maintain satisfactory compliance with certain privacy and data protections laws and regulations may harm our business.***

Complex local, state, national, foreign, and international laws and regulations apply to the collection, use, retention, protection, disclosure, transfer, and other processing of personal data. These privacy laws and regulations are quickly evolving, with new or modified laws and regulations proposed and implemented frequently and existing laws and regulations subject to new or different interpretations. In addition, our legal and regulatory obligations in jurisdictions outside of the U.S. are subject to unexpected changes, including the potential for regulatory or other governmental entities to enact new or additional laws or regulations, to issue rulings that invalidate prior laws or regulations, or to increase penalties significantly. Complying with these laws and regulations can be costly and can impede the development and offering of new products and services. For example, the E.U. General Data Protection Regulation (GDPR), imposes stringent data protection requirements and provides for significant penalties for noncompliance. Additionally the California Consumer Privacy Act (CCPA) requires, among other things, covered companies to provide disclosures to California consumers, and allow such consumers new abilities to opt-out of certain sales of personal data. The CCPA also provides for civil penalties for violations, as well as a private right of action for data breaches that may increase data breach litigation. In recent years, many other states have enacted privacy laws that have gone or will go into effect and which impose additional data protection obligations on covered businesses, including consumer rights, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. The new and proposed privacy laws may result in further uncertainty and would require us to incur additional expenditures to comply. These regulations and legislative developments have potentially far-reaching consequences and may require us to modify our data management practices and incur substantial compliance expense.

Our failure to comply with applicable laws and regulations or other obligations to which we may be subject relating to personal data, or to protect personal data from unauthorized access, use, or other processing, could result in enforcement actions and regulatory investigations against us, claims for damages by customers and other affected individuals, fines, damage to our reputation, and loss of goodwill, any of which could have a material adverse effect on our operations, financial performance, and business.

**<u>Responsible Business Risks</u>**

***We may be subject to environmental liabilities.***

We are subject to various federal, state and foreign laws and regulations, including those governing pollution, protection of human health, the environment and recently, those restricting the presence of certain substances in electronic products as well as holding producers of those products financially responsible for the collection, treatment, recycling and disposal of certain products. Such laws and regulations, passed in several jurisdictions in which we operate, are often complex and are subject to frequent changes. We will need to ensure that we comply with such laws and regulations as they are enacted, as well as all other environmental laws and regulations. As appropriate or required, our component suppliers must also comply with such laws and regulations. If we fail to comply with such laws, we could face sanctions for such noncompliance, and our customers may refuse to purchase our products, which would have a materially adverse effect on our business, financial condition and results of operations.

With respect to compliance with environmental laws and regulations in general, we have incurred, and in the future could incur, substantial costs for the cleanup of contaminated properties, either those we own or operate or to which we have sent wastes in the past, or to comply with such environmental laws and regulations. Additionally, we could be subject to disruptions to our operations and logistics as a result of such clean-up or compliance obligations. If we were found to be in violation of these laws, we could be subject to governmental fines and liability for damages resulting from such violations. If we have to make significant capital expenditures to comply with environmental laws, or if we are subject to significant expenditures in connection with a violation of these laws, our financial condition or operating results could be materially adversely impacted.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***Our business is subject to evolving regulations and expectations with respect to sustainability matters that could expose us to numerous risks.***

Regulators, customers, investors, employees and other stakeholders continue to focus on sustainability-related matters and related disclosures. These developments have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting sustainability-related requirements and expectations. For example, developing and acting on sustainability-related initiatives and collecting, measuring and reporting sustainability-related information and metrics can be costly, difficult and time consuming and is subject to evolving reporting standards, including reporting requirements in California and other jurisdictions, such as the European Union which we may be subject to. We may also communicate certain initiatives and goals regarding sustainability-related matters in our public disclosures. These sustainability-related initiatives and goals could be difficult and expensive to implement, the technologies needed to implement them may not be cost effective and may not advance at a sufficient pace, and we could be criticized for the accuracy, adequacy or completeness of the disclosure. Further, statements about our sustainability-related initiatives and goals, and progress against those goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If our sustainability-related data, processes and reporting are incomplete or inaccurate, or if we fail to achieve progress with respect to our sustainability-related goals on a timely basis, or at all, our reputation, business, financial performance and growth could be adversely affected.

***We may be subject to risks related to climate change, natural disasters and catastrophic events.***

We operate in geographic regions which face a number of climate and environmental challenges. Our corporate headquarters is located in Chandler, Arizona, a desert climate, subject to extreme heat and drought. The geographic location of our Northern California offices and production facilities subject them to drought, earthquake and wildfire risks. It is impossible to predict the timing, magnitude or location of such natural disasters or their impacts on the local economy and on our operations. If a major earthquake, wildfire or other natural disaster were to damage or destroy our facilities or manufacturing equipment, we may experience potential impacts ranging from production and shipping delays to lost profits and revenues. In the past, we temporarily closed our Santa Rosa, California facility due to wildfires in the region and the facility's close proximity to the wildfire evacuation zone which resulted in production stoppage. The location of our production facility could subject us to production delays and/or equipment and property damage. Moreover, the public electric utility in our Northern California region, has previously implemented and may continue to implement widespread blackouts during the peak wildfire season to avoid and contain wildfires sparked during strong wind events by downed power lines or equipment failure. Ongoing blackouts, particularly if prolonged or frequent, could impact our operations going forward. Additionally, the occurrence of adverse public health developments, epidemic disease or pandemics may adversely affect our business, operations, financial condition, and results of operations. The extent to which global pandemics impact our business going forward will depend on factors such as the duration and scope of the pandemic; governmental, business, and individuals' actions in response to the pandemic; and the impact on economic activity, including the possibility of recession or financial market instability. Measures to contain a global pandemic may intensify other risks described in these Risk Factors.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**<u>Risks Related to our Liquidity and Indebtedness</u>**

***Any deterioration or disruption of the capital and credit markets may adversely affect our access to sources of funding.***

Global economic conditions have caused and may cause volatility and disruptions in the capital and credit markets. When the capital or credit markets deteriorate or are disrupted, our ability to incur additional indebtedness to fund a portion of our working capital needs and other general corporate purposes, or to refinance maturing obligations as they become due, may be constrained. In the event that we were to seek to access the capital markets or other sources of financing, there can be no assurance that we will be able to obtain financing on acceptable terms or within an acceptable time, if at all. We may seek to access the capital or credit markets whenever conditions are favorable, even if we do not have an immediate need for additional capital at that time. For example, in December 2021, we entered into a $300 million asset-based secured credit facility (Senior Secured Asset-Based Revolving Credit Facility), maturing in December 2026, which has certain limitations based on our borrowing base capacity. The Company reduced the commitment under the Senior Secured Asset-Based Revolving Credit Facility to $200 million to be in line with borrowing base capacity and extended the maturity to October 2030. Our access to the financial markets and the pricing and terms we receive in the financial markets could be adversely impacted by various factors, including changes in financial markets and interest rates. In addition, if we do access the capital or credit markets, agreements governing any borrowing arrangement could contain covenants restricting our operations.

***Despite our current level of indebtedness, we and our subsidiaries may still be able to incur substantially more debt.***

We and our subsidiaries may be able to incur significant additional indebtedness in the future. The indentures that govern the Notes and the agreements that govern our secured credit facility and term loans contain restrictions on the incurrence of additional indebtedness, which are subject to a number of qualifications and exceptions, and the additional indebtedness incurred in compliance with these restrictions could be substantial. These restrictions also will not prevent us from incurring obligations that do not constitute indebtedness under the agreements governing our existing debt.

For example, in 2025, in connection with our acquisition of Spirent's HSE and CE business, we entered into a $600 million 7-year term loan facility and successfully allocated the loan to prospective lenders at an initial interest rate of SOFR+2.50% and an original issue price of 99.75%. The term loans, which mature on October 16, 2032, are secured by substantially all of the assets of the Company and those of its domestic subsidiaries.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***Our term notes and term loans increased our overall leverage and our convertible notes could dilute our existing stockholders and lower our reported earnings per share.*** 

The issuance of our 1.625% Senior Convertible Notes due 2026 (the "2026 Notes"), our 3.75% Senior Notes due 2029 and our 0.625% Senior Convertible Notes due 2031 (together the "Notes") as well as our Term Loan Credit Agreement substantially increased our principal payment obligations. The degree to which we are leveraged could materially and adversely affect our ability to successfully obtain financing for working capital, acquisitions or other purposes and could make us more vulnerable to industry downturns and competitive pressures. In addition, the holders of the 2026 Notes and 2031 Notes are entitled to convert the Notes into shares of our common stock or a combination of cash and shares of common stock under certain circumstances which would dilute our existing stockholders and lower our reported per share earnings. For example, on December 22, 2025 we exchanged $103.5 million aggregate principal amount of the 2026 Notes for an aggregate of 7.9 million shares which left approximately $49.0 million in aggregate principal amount of the 2026 Notes outstanding. In March 2026, the Company settled the remaining 2026 Notes through a combination of $49.0 million in cash and 1.8 million shares of its common stock. In addition, the Company paid $0.4 million of accrued interest in cash.

Our ability to make payments on our indebtedness when due, to make payments upon conversion with respect to our convertible senior notes or to refinance our indebtedness as we may need or desire, depends on our future performance and our ability to generate cash flow from operations, which is subject to economic, financial, competitive and other factors beyond our control. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. We may not be able to engage in these activities on desirable terms or at all, which may result in a default on our existing or future indebtedness and harm our financial condition and operating results.

***Our outstanding indebtedness may limit our operational and financial flexibility.***

Our level of indebtedness could have important consequences, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impairing our ability to obtain additional financing for working capital, capital expenditures, acquisitions or general corporate purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requiring us to dedicate a substantial portion of our operating cash flow to paying principal and interest on our indebtedness, thereby reducing the funds available for operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Limiting our ability to grow and make capital expenditures due to the financial covenants contained in our debt arrangements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impairing our ability to adjust rapidly to changing market conditions, invest in new or developing technologies, or take advantage of significant business opportunities that may arise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Making us more vulnerable if a general economic downturn occurs or if our business experiences difficulties; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Resulting in an event of default if we fail to satisfy our obligations under the Notes or our other debt or fail to comply with the financial and other restrictive covenants contained in the indentures governing the Notes, the Term Loan Credit Facility or any other debt instruments, which event of default, if not cured or waived, could result in all of our debt becoming immediately due and payable and could permit certain of our lenders to foreclose on our assets securing such debt. This could have a material adverse effect on our business, operating results or financial condition.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***We may not generate sufficient cash flow to meet our debt service and working capital requirements, which may expose us to the risk of default under our debt obligations.***

We will need to implement our business strategy successfully on a timely basis to meet our debt service and working capital needs. We may not successfully implement our business strategy, and even if we do, we may not realize the anticipated results of our strategy and generate sufficient operating cash flow to meet our debt service obligations and working capital needs. In addition, our ability to make scheduled payments on our indebtedness, including the Notes, is affected by general and regional economic, financial, competitive, business and other factors beyond our control. For example, we generate cash in a number of jurisdictions globally, including China, in which there can be challenges to repatriate those funds which can impact our overall liquidity.

In the event our cash flow is inadequate to meet our debt service and working capital requirements, we may be required, to the extent permitted under the indentures covering the Notes and any other debt agreements, to seek additional financing in the debt or equity markets, refinance or restructure all or a portion of our indebtedness, sell selected assets or reduce or delay planned capital or operating expenditures. Any insufficient cash flow may make it more difficult for us to obtain financing on terms that are acceptable to us, or at all.

***The terms of the indentures that govern the Notes and the agreements that govern our secured credit facility and our term loan facility restrict our current and future operations.***

The indentures governing the Notes and the agreements governing the secured credit facility and the term loan facility contain a number of restrictive covenants that impose significant operating and financial restrictions on us and may limit our ability to engage in acts that may be in our long-term best interest, including restrictions on our ability to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incur or guarantee additional indebtedness;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incur or suffer to exist liens securing indebtedness;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Make investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidate, merge or transfer all or substantially all of our assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sell assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pay dividends or other distributions on, redeem or repurchase capital stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enter into transactions with affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amend, modify, prepay or redeem subordinated indebtedness;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enter into certain restrictive agreements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Engage in a new line of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amend certain material agreements, including material leases and debt agreements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enter into sale leaseback transactions.

**<u>Tax Risks</u>**

***Our ability to use our net operating loss carryforwards to offset future taxable income may be subject to certain limitations and/or changes in regulations.***

Changes in U.S. federal income or other tax laws or the interpretation of tax laws may impact our tax liabilities. Utilization of our net operating losses (NOLs) and tax credit carryforwards may be subject to a substantial annual limitation if the ownership change limitations under Sections 382 and 383 of the Internal Revenue Code and similar state provisions are triggered by changes in the ownership of our capital stock. In general, an ownership change occurs if there is a cumulative change in our ownership by "5-percent shareholders" that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Accordingly, purchases of our capital stock by others could limit our ability to utilize our NOLs and tax credit carryforwards in the future.

Furthermore, we may not be able to generate sufficient taxable income to utilize our NOLs and tax credit carryforwards before they expire. Due to uncertainty regarding the timing and extent of our future profitability, we continue to record a valuation allowance to offset our U.S. and certain of our foreign deferred tax assets because of uncertainty related to our ability to utilize our NOLs and tax credit carryforwards before they expire.

If any of these events occur, we may not derive some or all of the expected benefits from our NOLs and tax credit carryforwards.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

***Changes in tax legislation or policies could materially impact our financial position and results of operations.***

VIAVI operates in many jurisdictions around the world. Global tax policy is in a heightened state of evolution, with particular attention to Base Erosion and Profit Shifting (BEPS), transfer pricing, and general corporate tax reform. Any substantial changes in domestic or international corporate tax policies, regulations, or guidance may materially adversely affect our business, the amount of taxes we are required to pay, and our financial condition and results of operations generally. Enforcement activities or legislative initiatives may also have similar effects.

The Organization for Economic Co-operation and Development (OECD) issued the BEPS Pillar Two Model Rules, which establish a minimum global effective tax rate of 15% on the profits of large multinational companies. Although the United States has not adopted these rules, many countries in which we operate have either implemented or are expected to implement the OECD Pillar Two framework. These developments may increase our tax burden, reduce net income, and impact cash flow.

The Pillar Two rules generally became effective starting with VIAVI's fiscal 2025. We consider these laws when recording our income tax provision under ASC 740.

In June 2025, the United States and the G7 countries announced an agreement in principle to modify the Pillar Two rules. Under this agreement, the foreign and domestic profits of U.S.-parented groups would be excluded from Pillar Two's undertaxed profit rule and income inclusion rule. In exchange, the U.S. withdrew the Section 899 tax provision from the One Big Beautiful Bill Act (OBBBA), which had imposed a retaliatory tax on individuals and entities from countries that implement certain "unfair foreign taxes" against U.S. companies or citizens. The G7-U.S. agreement has not yet been enacted into law, and we continue to evaluate our Pillar Two position based on legislation currently in force. We will monitor tax developments for any future implications with respect to our tax burden, net income, and cash flow.

**<u>General Risks</u>**

***Certain provisions in our charter and under Delaware laws could hinder a takeover attempt.***

We are subject to the provisions of Section 203 of the Delaware General Corporation Law prohibiting, under some circumstances, publicly-held Delaware corporations from engaging in business combinations with some stockholders for a specified period of time without the approval of the holders of substantially all of our outstanding voting stock. Our certificate of incorporation and bylaws contain provisions granting our Board of Directors the authority to establish additional series of preferred stock and to designate the rights, preferences and privileges of such shares (commonly known as "blank check preferred"), and provisions permitting our stockholders to take action only at a duly called annual or special meeting of stockholders, which may only be called by the Chairman of the Board, the Chief Executive Officer or the Board of Directors. These provisions may have the effect of deterring hostile takeovers or delaying changes in control or change in our management.

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

Our common stock is traded on the Nasdaq Global Select Market under the symbol "VIAV". As of April 25, 2026, we had 1,303 holders of record of our common stock. We have not paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future.

There were no shares repurchased under our 2022 Repurchase Plan during the three months ended March 28, 2026, with remaining authorization of $168.4 million for future share repurchases. Refer to "Note 15. Stockholders' Equity" for more details.

**Item 3. Defaults Upon Senior Securities**

None

**Item 4. Mine Safety Disclosures**

None.

**Item 5. Other Information**

<u>Rule 10b5-1 Trading Arrangements</u>

None of VIAVI's directors or Section 16 officers adopted, modified or terminated a trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a "non-Rule" 10b5–1 trading arrangement, as those terms are defined in Regulation S-K, Item 408, during the fiscal quarter ended March 28, 2026.

**Item 6. Exhibits**

The exhibits required to be filed herewith by Item 601 of Regulation S-K, as described in the following index of exhibits, are attached hereto unless otherwise indicated as being incorporated by reference, as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Filed** | **Furnished** |
| **Exhibit No.** | **Exhibit Description** | **Form** | **Exhibit** | **Filing Date** | **Herewith** | **Not Filed** |
| <u>[31.1](viavq3fy2610-q1ex311x302ceo.htm)</u> | <u>[Certification of the Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](viavq3fy2610-q1ex311x302ceo.htm)</u> |  |  |  | X |  |
| <u>[31.2](viavq3fy262xex312x302cfo.htm)</u> | <u>[Certification of the Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](viavq3fy262xex312x302cfo.htm)</u> |  |  |  | X |  |
| <u>[32.1](viavq3fy263xex321x906ceo.htm)</u> | <u>[Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](viavq3fy263xex321x906ceo.htm)</u> |  |  |  |  | X |
| <u>[32.2](viavq3fy264xex322x906cfo.htm)</u> | <u>[Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](viavq3fy264xex322x906cfo.htm)</u> |  |  |  |  | X |
| 101.SCH | Inline XBRL Taxonomy Extension Schema |  |  |  | X |  |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | X |  |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | X |  |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | X |  |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | X |  |
| 104 | Cover Page Interactive Data File - (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  | X |  |

---

------

<u>[**Table of Contents**](#i9d5e57b28a2a4895b07b82f12543ee34_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| Date: April 30, 2026 | VIAVI SOLUTIONS INC. | VIAVI SOLUTIONS INC. |
|  | (Registrant) | (Registrant) |
|  | By: | /s/ ILAN DASKAL |
|  | Name: | ILAN DASKAL |
|  | Title: | Executive Vice President and Chief Financial Officer |
|  |  | (Duly Authorized Officer and Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**VIAVI SOLUTIONS INC.**

**CERTIFICATION PURSUANT TO SECTION 302**

**OF THE SARBANES-OXLEY ACT OF 2002**

I, Oleg Khaykin, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Viavi Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: April 30, 2026

---

| |
|:---|
| /s/ OLEG KHAYKIN |
| Oleg Khaykin<br>*Chief Executive Officer* <br>*(Principal Executive Officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**VIAVI SOLUTIONS INC.**

**CERTIFICATION PURSUANT TO SECTION 302**

**OF THE SARBANES-OXLEY ACT OF 2002**

I, Ilan Daskal, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Viavi Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: April 30, 2026

---

| |
|:---|
| /s/ ILAN DASKAL |
| Ilan Daskal |
| *Executive Vice President and Chief Financial Officer* |
| *(Duly Authorized Officer and Principal Financial and Accounting Officer)* |

---

## Exhibit 32.1

**Exhibit 32.1**

**VIAVI SOLUTIONS INC.**

**CERTIFICATION PURSUANT TO SECTION 906**

**OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Viavi Solutions Inc. (the "Company") on Form 10-Q for the quarter ended March 28, 2026 as filed with the Securities and Exchange Commission (the "Report"), I, Oleg Khaykin, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

Dated: April 30, 2026

---

| |
|:---|
| /s/ OLEG KHAYKIN |
| Oleg Khaykin |
| *Chief Executive Officer* |
| *(Principal Executive Officer)* |

---

## Exhibit 32.2

**Exhibit 32.2**

**VIAVI SOLUTIONS INC.**

**CERTIFICATION PURSUANT TO SECTION 906**

**OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Viavi Solutions Inc. (the "Company") on Form 10-Q for the quarter ended March 28, 2026 as filed with the Securities and Exchange Commission (the "Report"), I, Ilan Daskal, Executive Vice President and Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

Dated: April 30, 2026

---

| |
|:---|
| /s/ ILAN DASKAL |
| Ilan Daskal |
| *Executive Vice President and Chief Financial Officer* |
| *(Duly Authorized Officer and Principal Financial and Accounting Officer)* |

---

<br>